Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase

1 . A method for treating a cognitive disorder or deficit comprising administering an effective amount of the compound of Formula (I):

or a pharmaceutically acceptable salt thereof, wherein

Z is selected from the group consisting of —N(R 1 )OR 2 and H;

L is selected from the group consisting of a covalent bond and —N(OR 2 )—;

wherein, when L is —N(OR 2 )—, Z is H; and

wherein, when Z is H, L is —N(OR 2 )—;

J is selected from the group consisting of a covalent bond, ═CH—, —C 1 -C 8 alkyl-, —C 0 -C 3 alkyl-C 1 -C 8 heteroalkyl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C 2 -C 8 alkenyl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C 2 -C 8 alkynyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 heteroalkyl-, —C 0 -C 3 alkyl-C 1 -C 6 heteroalkyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 3 alkyl-C 1 -C 6 heteroalkyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-cycloalkyl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 6 alkyl-, —C 4 -C 6 heterocyclyl-aryl-C 0 -C 6 alkyl-, —C 4 -C 6 heterocyclyl-aryl-C 0 -C 6 heteroalkyl-, —C 0 -C 6 alkyl-C 4 -C 6 heterocyclyl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkylheteroaryl-C 0 -C 6 heteroalkyl-, —C 4 -C 6 heterocyclyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkynyl-, —C 0 -C 6 alkyl-heteroaryl-C 2 -C 6 alkynyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkynyl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 3 alkyl-C 2 -C 6 alkenyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 3 alkyl-C 2 -C 6 alkenyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 3 alkyl-C 2 -C 6 alkynyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 3 alkyl-C 2 -C 6 alkynyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkylaryl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkylaryl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 3 alkyl-heteroaryl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-heteroaryl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-aryl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-aryl-aryl-C 0 -C 3 alkyl-, and —C 0 -C 6 alkyl-C 3 -C 6 cycloalkyl-C 0 -C 6 alkyl-, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, heterocyclyl, and cycloalkyl moiety is optionally substituted, and wherein when J is ═CH—, Q is a covalent bond and B is attached through a carbon sp 2 to J;

Q is selected from the group consisting of an optionally substituted:

or where possible, an (R,R) or (S,S) enantiomer or a mixture of enantiomers thereof,

wherein G and G 1 are independently selected from carbon and N; the variables I, m, n, o and p denote numbers that are each independently selected from 0, 1, 2 or 3 provided that the sum total of l, m, n, o and p is 4, 5, 6 or 7, such that the group represented by Q comprises a 6, 7, 8 or 9 membered bridged or fused heterocyclyl, respectively, and further provided that when G and G 1 are both N then the sum total of l and o is not zero, and the sum total of m and p is not zero, and wherein n is an integer ranging from 0 to 3; (preferably, Q comprises a 7 or 8-membered ring; in one particular embodiment, n is zero, such that Q comprises a fused bicyclic ring);

U is selected from the group consisting of —C 0 -C 8 alkyl-C(O)—C 0 -C 3 alkyl-, —C 1 -C 8 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-O—C(O)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—C(S)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-O—C(S)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—S(O) 2 —C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-heterocyclyl-C 0 -C 3 alkyl-, a covalent bond and —O—C 2 -C 4 alkyl-; and

U 1 is selected from the group consisting of H, —C(R 1 )(R 2 )—, —C 0 -C 8 alkyl-C(O)—C 0 -C 3 alkyl-, —C 1 -C 8 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-, —C(R 1 )(R 2 )—N(R 3 )—C(O)—C 0 -C 3 alkyl-, —C(R 1 )(R 2 )—C(O)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-O—C(O)—C 0 -C 3 alkyl-, —C(R 1 )(R 2 )—O—C(O)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—C(S)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-O—C(S)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—S(O) 2 —C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-heterocyclyl-C 0 -C 3 alkyl-, a covalent bond, (R 3 )(R 3a )N—C 2 -C 4 alkyl-, —O—C 2 -C 4 alkyl-, and R 3 —O—C 2 -C 4 alkyl-;

or

Q is selected from the group consisting of a covalent bond, —C 1 -C 8 alkyl-, —C 1 -C 8 alkyl-, —C 1 -C 8 heterocyclyl-, ═N—O—, —C 0 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S(O) 0-2 -C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-cycloalkyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)-cycloalkyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )-cycloalkyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S(O) 0-2 —N(R 3 )-cycloalkyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—N(R 3 )-cycloalkyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C(O)—O-cycloalkyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—O-cycloalkyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-(CR 3 ═CR 3 ) 1-2 -C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-(C≡C) 1-2 —C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)-alkenyl-C 0 -C 4 alkyl-, —C 0 -C 6 alkyl-C(O)—N(R 3 )—C 0 -C 4 alkyl-, —C 0 -C 6 alkyl-SO 2 —N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—SO 2 —C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—S(O) 2 —N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S(O) 2 —C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—N(R 3 )—C 0 -C 3 alkyl-, ═N—O—C 0 -C 3 alkyl-, -heterocyclyl-C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —SO 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C(O)—C 0 -C 6 alkyl-bridged heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —O—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —O—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—S(O) 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-SO 2 —N(R 3 )—, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—N(R 3 )— and —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—O—, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted; wherein

is selected from the group consisting of b-1a to b-1k and b-1 to b-125, and wherein when Q is attached to

via ═N—O—, or ═N—O—C 0-3 alkyl, it is attached through carbon sp 2 in

and wherein each alkyl, heteroalkyl, cycloalkyl, heterocyclyl and alkenyl moiety is optionally substituted; and wherein when Q is a covalent bond and J is attached to

via ═CH—, then it is attached through carbon sp 2 in

or

when

is selected from the group consisting of b-1 to b-121 and is attached to Q via a N in

then Q is selected from the group consisting of a covalent bond, —C(O)—C 1 -C 3 alkyl-O—, —C 1 -C 8 alkyl-, —C 2 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 1 -C 6 alkyl-(CR 3 ═CR 3 ) 1-2 -C 0 -C 6 alkyl-, —C 1 -C 6 alkyl-(C≡C) 1-2 -C 0 -C 6 alkyl-, —C 2 -C 6 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl, —C 2 -C 6 alkyl-N(R 3 )—C(O)-alkenyl-C 0 -C 3 alkyl, —C 0 -C 6 alkyl-C(O)—N(R 3 )—C 0 -C 4 alkyl-, —C(O)—O—C 0 -C 4 alkyl, —C 0 -C 6 alkyl-S(O) 2 —N(R 3 )—C 0 -C 3 alkyl, —C 2 -C 6 alkyl-N(R 3 )—S(O) 2 —C 0 -C 3 alkyl, —C 2 -C 3 alkyl-N(R 3 )—S(O) 2 —N(R 3 )—C 0 -C 3 alkyl-, —C 2 -C 6 alkyl-S—C 0 -C 3 alkyl, —C 2 -C 6 alkyl-S(O)—C 0 -C 3 alkyl, —C 0 -C 6 alkyl-S(O) 2 —C 0 -C 3 alkyl, —C 2 -C 6 alkyl-N(R 3 )—C(O)—N(R 3 )—C 0 -C 3 alkyl, —C 2 -C 3 alkyl-C═N—O—C 0 -C 3 alkyl, —SO 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 2 -C 4 alkyl-N(R 3 )—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 2 -C 4 alkyl-O—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 2 -C 4 alkyl-N(R 3 )—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 2 -C 4 alkyl-O—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 2 -C 4 alkyl-N(R 3 )—S(O) 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-S(O 2 )—N(R 3 )—, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—N(R 3 )— and —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—O—, wherein each alkyl, heterocyclyl and alkenyl moiety is optionally substituted, and wherein the heterocyclyl moiety is optionally bridged with —(CH 2 ) 0-3 —;

R 1 and R 2 are independently selected from the group consisting of —H, C 1 -C 6 alkyl, aryl, heteroaryl, heterocyclyl, cycloalkyl and a protecting group;

each R 3 is independently selected from the group consisting of —H, alkyl, C 0 -C 3 alkyl-heterocyclyl, C 1 -C 3 alkyl-C 2 -C 6 alkenyl, C 1 -C 3 alkyl-C 2 -C 3 alkynyl, —C 2 -C 4 alkyl-OR 1 , —C 2 -C 4 alkyl-NR 3b R 3c , —C 2 -C 4 alkyl-NR 1 R 2 , heteroalkyl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C(O)—NR 3b R 3c , —C(O)—NR 1 R 2 , —C(O)—OR 1 , —S(O) 2 —NR 1 R 2 , —S(O) 2 —R 1 , —C(O)—R 1 , —C 3 -C 6 cycloalkyl, —C 0 -C 3 alkyl-C 3 -C 7 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, C 0 -C 3 alkyl-heteroaryl and heteroaryl, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted with from one to three independently selected substituents;

each R 3a is independently selected from the group consisting of —H, alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl, covalent bond, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted;

wherein R 3 and R 3a , together with the atom to which they are attached, optionally form a heterocyclic ring, wherein the heterocyclyl moiety is optionally substituted;

wherein R 3b and R 3c , together with the atom to which they are attached, optionally form a heterocyclic ring, wherein the heterocyclyl moiety is optionally substituted;

provided that

is absent when Q is structure (a-1), (a-2), (a-3), (a-20) or when U 1 is H, N(R 3 )(R 3a )—C 2 -C 4 alkyl- or R 3 —O—C 2 -C 4 alkyl-;

is selected from the group consisting of hydrogen, aryl, aryl-alkyl-, heteroaryl, heteroaryl-alkyl-, heterocyclyl, cycloalkyl, heterocyclyl-alkyl, cycloalkyl-alkyl, C 1 -C 10 alkyl, (aryl) 2 -CH—C 0 -C 6 alkyl-, (aryl)(heteroaryl)CH—C 0 -C 6 alkyl- and (heteroaryl) 2 CH—C 0 -C 6 alkyl-, each of which is optionally substituted; or

is a radical selected from the group consisting of

wherein

and are independently selected from phenyl or a 5- or 6-membered heteroaryl, wherein each of which is optionally substituted with one to three substituents;

provided that when

is selected from the group consisting of hydrogen, aryl, aryl-alkyl-, heteroaryl, heteroaryl-alkyl-, heterocyclyl, cycloalkyl, heterocyclyl-alkyl, cycloalkyl-alkyl, C 1 -C 10 alkyl, (aryl) 2 -CH—C 0 -C 6 alkyl-, (arylXheteroaryl)CH—C 0 -C 6 alkyl- and (heteroaryl) 2 CH—C 0 -C 6 alkyl-, each of which is optionally substituted, then Q is selected from the group consisting of a-3, a-4, a-5, a-6, a-7, a-8, a-9, a-10, a-11, a-12, a-13 and a-14,

wherein

each A is independently selected from the group consisting of N, —N-oxide, —CH═ and —C(R 4 )═, wherein no more than two A per 5 or 6 membered ring are N in a

group, and wherein no more than one A is —N-oxide;

the group M 1 -M 2 is selected from the group consisting of a covalent bond, —N(R 3 )CH 2 —, —CH 2 N(R 3 )—, —S(O) 0-2 —CH 2 —, —CH 2 S(O) 0-2 —, —O—CH 2 —, —CH 2 —O—, —C(O)N(R 3 )—, —C(O)—O—, —C(O)—CH 2 —, —CH(OH)—CH 2 —, —CH(F)—CH 2 —, —CH 2 —C(O)—, —CH 2 —CH(OH)—, —CH 2 —CH(F)—, —N(R 3 )—C(O)—, —SO 2 N(R 3 )—, —N(R 3 )SO 2 —, —CH(R 4 )CH 2 —, —CH 2 CH(R 4 )—, —N═C(R 4 )—, —C(R 4 )═N—, —CH 2 —CH 2 —, —CH═CH—, —CH(R 3 )—CH(R 3 )—, —C(R 3 )═C(R 3 )—, —C(R 4 )═C(R 4 )—, —CF═CH—, —CH═CF—,

—CH 2 —, —C(R 3 )(R 3a )—, —S(O) 0-2 —, —N(R 3 )—, or absent;

M 3 is selected from the group consisting of

or M 3 is

wherein Q is attached to

via ═N—O—, or ═N—O—C 0-3 alkyl, or J is attached to

via ═CH—,

wherein * represents the point of attachment to Q;

M 4 is selected from the group consisting of

and covalent bond;

wherein, when M 1 -M 2 is a covalent bond, M 4 is selected from the group consisting of

the groups D 1 -D 2 and D 1a -D 2a are selected from the group consisting of

wherein, * represents the point of attachment to Q;

D 3 is selected from the group consisting of a covalent bond,

wherein the

optionally substituted;

D 4 is selected from the group consisting of

wherein the

is optionally substituted;

the group E 1 -E 2 is selected from the group consisting of

wherein * represents the point of attachment to Q; and

E 3 is selected from the group consisting of —C(O)—, —C(S)—, —CH 2 —, —C(OH) 2 — and —C═N(R 3 )—; and

R 4 is independently selected from the group consisting of —H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl-R 3 , —C 0 -C 6 alkyl-OR 3 , —C 0 -C 6 alkyl-OR 1 , —C 0 -C 6 alkyl-C(O)—OR 3 , —C 0 -C 6 alkyl-C(O)NR 3 R 3a , —CH═CH—C(O)—OR 3 , —CH═CH—C(O)—N(R 3 )(R 3a ), —N(R 3 )—C(O)—CF 3 , —N(R 3 )—C 2 -C 6 alkyl-N(R 3 )(R 3a ), —C 0 -C 6 alkyl-N(R 3 )(R 3a ), —N(R 3 )—C(O)—C 1 -C 6 alkyl-R 3 , —N(R 3 )—S(O) 2 —C 1 -C 6 alkyl-R 3 , —S(O) 2 —N(R 3 )R 3a , —O—C 2 -C 6 alkyl-N(R 3 )(R 3a ), —O—C 2 -C 6 alkyl-OR 1 , —S—R 3 , —S(O)—C 1 -C 6 alkyl-R 3 , —S(O) 2 —C 1 -C 6 alkyl-R 3 , C 3 -C 6 cycloalkyl, heterocyclyl, C 4 -C 7 heterocyclyl-R 3 , —O—C 2 -C 4 alkyl-heterocyclyl, —O-heterocyclyl-C(O)—OR 3 , —O—C 0 -C 4 alkyl-aryl, —O—C 0 -C 4 alkyl-heteroaryl, —O—C(O)—NR 3 -C 0 -C 4 alkyl-aryl, —O—C(O)—NR 3 -C 0 -C 4 alkyl-heteroaryl, —O—C 0 -C 4 alkyl-heterocyclylaryl, —O—C 0 -C 4 alkyl-heterocyclyl-heteroaryl, —N(R 3 )—C 2 -C 4 alkyl-heterocyclyl, —N(R 3 )C(O)N(R 3 )—C 0 -C 4 alkyl-heterocyclyl-R 3 , —C 0 -C 4 alkyl-OC(O)—R 3 , —C 0 -C 4 alkyl-N(R 3 )C(O)—O—R 3 , —C 0 -C 4 alkyl-heterocyclyl-C(O)—O—R 3 , —N(R 3 )—C 2 -C 4 alkyl-heterocyclyl, F, Cl, Br, I, NO 2 , —CF 3 , —OCF 3 , —OCHF 2 , —SCF 3 , —SF 5 , —SO 3 H, —CN, —C 1 -C 6 alkylaryl, aryl, heteroaryl, cycloalkyl, —C 1 -C 6 alkylheteroaryl, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moeity of the aformentioned R 4 is optionally substituted;

or

is selected from the group consisting of structures b-1a to b-1k and (b-1) to (b-125) and Q-J-L taken together is selected from the group consisting of —C 3 -C 8 alkyl-, —C(O)—C 3 -C 8 alkyl-, —C 0 -C 3 alkyl-O—C 3 -C 8 alkyl-, —C 0 -C 3 alkyl-C 1 -C 4 alkenyl-C 0 -C 3 alkyl-, ═N—O—C 1 -C 8 alkyl-, ═N—O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, ═N—O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkenyl-, ═N—O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkynyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkenyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkynyl-, —C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl-, —C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl-, —C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-heteroaryl-C 1 -C 3 alkenyl-, —C 0 -C 3 alkyl-heteroaryl-C 1 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-ayl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 2 -C 4 alkyl-O—C 1 -C 3 alkyl-heteroayl-C 2 -C 3 alkenyl-, —C 2 -C 4 alkyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-N(R 3 )-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U—N(R 3 )-bridged heterocyclyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-N(R 3 )-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U—N(R 3 )-bridged heterocyclyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-N(R 3 )-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U—N(R 3 )-bridged heterocyclyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-N(R 3 )-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U—N(R 3 )-bridged heterocyclyl-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-U-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-N(R 3 )-bridged heterocyclyl-U-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-N(R 3 )—U-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-U-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-N(R 3 )-bridged heterocyclyl-U-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-N(R 3 )—U-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-U-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-N(R 3 )-bridged heterocyclyl-U-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-N(R 3 )—U-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-U-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-N(R 3 )-bridged heterocyclyl-U-heteroaryl-C 2 -C 6 alkenyl-, and —C 0 -C 6 alkyl-bridged heterocyclyl-N(R 3 )—U-heteroaryl-C 2 -C 6 alkenyl-,

wherein each alkyl, alkenyl, aryl, alkynyl, heteroaryl and heterocyclyl moiety is optionally substituted; and wherein the bridge is methylene or propylene;

provided that Formula (I) excludes those compounds wherein

-Q-J-L-C(O)Z is optionally substituted —C 1 -C 13 alkyl-N(R 3 )—C 0 -C 6 alkyl-aryl-C 2 alkenyl-C(O)NHOH; and

is selected from the group consisting of aromatic polycycles, non-aromatic polycycles, mixed aryl and non-arylpolycycles, polyheteroaryl, non-aromatic polyheterocycles, and mixed aryl and non-aryl polyheterocycles, each of which is optionally substituted;

and

provided that Formula (I) excludes compounds of Formula (A)

wherein R906 is selected from the group consisting of aryl and heteroaryl;

T 906 is selected from the group consisting of —C 0-6 alkyl-S(O) 2 —C 0-6 alkyl-, —C 0-6 alkyl-C(O)—C 0-6 alkyl- and C 1-3 alkyl, wherein T 906 is substituted at the carbon atom attached to R 906 with a moiety selected from the group consisting of; aryl, heteroaryl, cycloalkyl and heterocycle;

A 906 is an optionally substituted unbridged heterocycle;

Q 906 is a bond;

Het is an optionally substituted 5-membered aryl ring;

L 906 is a bond or —C 1-4 alkyl-; and

R 906a is —N(R 906b )OH, wherein R 906b is selected from the group consisting of H, optionally substituted alkyl and optionally substituted aryl;

and

provided that Formula (I) excludes those compounds wherein

-Q-J-L-C(O)Z is optionally substituted —C 0 -C 4 alkyl-X—C 1 -C 4 alkyl-phenyl-C 2 alkenyl-C(O)NHOH;

is a 5- or 6-membered aromatic heterocyclic group condensed with a carbon ring or other heterocyclic ring, which

is substituted with 1 to 4 substituents selected from phenyl, another 5- or 6-membered aromatic heterocyclic group and a heterocyclic group, said heterocyclic group being optionally substituted with C 1-4 alkyl, a benzyl group or a pyridylmethyl group; and

X is a moiety having a structure selected from the group consisting of —C(O)N(R A1 )—, —O—C(O)—N(R A1 )—, —SO 2 —, —N(R A2 )SO 2 —, wherein R A1 and R A2 are independently —H or optionally substituted C 1 -C 4 alkyl;

and

provided that Formula (I) excludes compounds wherein B-Q- is

and

-J-L- is

wherein R is directly attached or attached through a linker, and is selected from the group consisting of substituted or unsubstituted aryl, cycloalkyl, cycloalkylamino, naphtha, pyridineamino, piperidino, 9-purine-6-amine, thiazoleamino group, hydroxyl, branched or unbranched alkyl, alkenyl, alkyoxy, aryloxy, arylalkyloxy and pyridine group, wherein the linker is selected from the group consisting of an amide moiety, —O—, —S—, —NH— and —CH 2 —; and

provided that Formula (I) excludes compounds of Formula (B)

wherein

R B is H or phenyl;

A B is a bi- or tricyclic residue optionally partially or totally unsaturated, and which optionally contains one or more heteroatoms selected from the group consisting of N, S and O, and optionally substituted by hydroxy, alkanoyloxy, primary, secondary or tertiary amino, aminoC 1 -C 4 alkyl, mono- or di(C 1 -C 4 )alkyl-aminoC 1 -C 4 alkyl, halogen, C 1 -C 4 alkyl and tri(C 1 -C 4 )alkylammoniumC 1 -C 4 alkyl;

is a chain of 1 to 5 carbon atoms optionally containing a double bond or an NR group, wherein R is H or C 1 -C 4 alkyl;

X B is absent, an oxygen atom or an NR group, wherein R is H or C 1 -C 4 alkyl; and

B B is a phenylene or cyclohexylene ring;

and

provided that Formula (I) excludes compounds of Formula (D)

wherein

A D is selected from the group consisting of a 4- to 10-membered aromatic or non-aromatic heterocyclyl;

X D is C═O or S(O) 2 ;

R D1 is H or C 1 -C 6 alkyl;

R D2 is independently selected from the group consisting of oxo, (C═O)—NH 2 , C 1 -C 6 alkyl-aryl and heterocyclyl, when A D is a non-aromatic heterocycle, wherein said alkyl, and aryl moieties are optionally substituted with one to three R b ; or

R D2 is independently selected from the group consisting of OH, NO 2 , (C═O) 0-1 —O 0-1 —C 1 -C 6 alkyl, CN, (C═O) 0-1 —O 0-1 —C 3 -C 10 cycloakyl, halogen, (C═O) 0-1 —N(R a ) 2 , CF 3 , NH—S(O) 0-2 —R a , (C═O) 0-1 —O 0-1 -heterocyclyl, (C═O) 0-1 —O 0-1 -aryl, S(O) 0-2 —R a , NH(C═O)R a , C 1 -C 6 alkyl-aryl and heterocyclyl, when A D is an aromatic heterocyclyl, wherein said alkyl, cycloalkyl, aryl and heterocyclyl are optionally substituted with one to three R b ;

R a is independently H or C 1 -C 6 alkyl; and

R b is independently selected from the group consisting of oxo, NO 2 , N(R a ) 2 , OH, CN, halogen, CF 3 and C 1 -C 6 alkyl;

and

provided that Formula (I) excludes compounds of Formula (E)

wherein

A E is selected from the group consisting of —CH 2 —O—, —CH 2 —S—, —CH 2 —CH 2 — and —NH—CO—;

X E is selected from the group consisting of —N(R E3 )—, ═C(O) and —CH(OH)—;

Y E is selected from the group consisting of O, S and —N(R E4 )—;

Z E is selected from the group consisting of a straight chain C4-C8alkylene, wherein one CH 2 group may be replaced by an oxygen or a sulfur atom, or wherein 2 carbon atoms form a C═C double bond, and which is either unsubstituted or substituted by one or two substituents selected from C 1 -C 4 alkyl and halogen;

R E1 and R E2 are independently selected from the group consisting of H, halogen, C 1 -C 4 alkyl, trifluoromethyl, hydroxy, C 1 -C 4 alkoxy, benzyloxy, C 1 -C 3 alkylenedioxy, nitro, amino, C 1 -C 4 alkylamino, di[(C 1 -C 4 )alkyl]-amino, and C 1 -C 4 alkanoylamino; and

R E3 and R E4 are independently selected from H and C 1 -C 4 alkyl; and

provided that Formula (I) excludes compounds of Formula (F)

A F -Q 1F -J F -Q 2F -C(O)—NH—OH  (F)

wherein

A F is a C 5 -C 20 aryl group or a 5-20 membered heteroaryl group, each having one ring or two or more fused rings, wherein at least one ring is aromatic, said ary and heteroaryl groups being optionally substituted;

Q 1F is a linker group having a backbone length of at least 2 carbon atoms, the linker being optionally substituted;

J F is —N(R F )—C(O)— or —C(O)—N(R F )—;

Q 2F is selected from the group consisting of C 1 -C 10 alkyl, C 5 -C 20 aryl, 5 to 20 membered heteroaryl, C 5 -C 20 aryl-C 1 -C 10 alkyl, 5 to 20 membered heteroaryl-C 1 -C 10 alkyl, C 1 -C 10 alkyl-C 5 -C 20 aryl and C 1 -C 10 alkyl-5 to 20 membered heteroaryl, each of which is optionally substituted; and

R F is selected from the group consisting of H, C 1 -C 7 alkyl, C 3 -C 20 heterocyclyl and C 5 -C 20 aryl, each of which is optionally substituted; and

provided that Formula (I) excludes compounds wherein

Z is —N(R 1 )(OR 2 );

R 1 and R 2 are independently selected from the group consisting of H, C 1 -C 6 alkyl, aryl and heteroaryl;

L is a bond; and

is selected from the group consisting of hydrogen, aryl, aryl-alkyl-, heteroaryl, heteroaryl-alkyl-, heterocyclyl, cycloalkyl, heterocyclyl-alkyl, cycloalkyl-alkyl, C 1 -C 10 alkyl, (aryl) 2 -CH—C 0 -C 6 alkyl-, (aryl)(heteroaryl)CH—C 0 -C 6 alkyl- and (heteroaryl) 2 CH—C 0 -C 6 alkyl-, each of which is optionally substituted; and

Q comprises a ring selected from the group consisting of

wherein Y F is nitrogen or —CH<, and Z F is oxygen, NH or —CH 2 — if Z F is not bonded to

or Z F is nitrogen or —CH< if Z F is bonded to

or

is selected from the group consisting of b-53, b-62 (wherein D 3 is

b-69 (wherein R 4 is H), b-70, b-72 (wherein D 3 is

b-92 and b-93; and

Q-J is selected from the group consisting of —X F —C 0-4 alkyl-aryl-C 0-4 alkyl-, —X F —C 0-4 alkyl-heteroaryl-C 0-4 alkyl-, and —X F —C 0-4 alkyl-heterocyclyl-C 0-4 alkyl-, wherein said alkyl, aryl, heteroaryl, and heterocyclyl are optionally substituted, and wherein said hetercyclyl is a mono- or bi-saturated or mono- or bi-unsaturated heterocyclic ring, and wherein

X F is selected from the group consisting of

wherein the left side attaches to

and wherein r and s are each independently 0, 1, 2, 3, 4 or 5, wherein r and s cannot be both 0 and when r or s are 0 then a direct bound in intended; each r′ is independently 0, 1, 3, 3 or 4 and r′ cannot be 0 when s is 0; R 4A is H, C 1-6 alkyl or phenyl; Y F is nitrogen or —CH<, and Z F is oxygen, NH or —CH 2 — if Z F is not bonded to

or Z F is nitrogen or —CH< if Z F is bonded to

and

provided that Formula (I) excludes those compounds having the following structure:

wherein

X 9 is selected from the group consisting of CO, SO 2 and CH 2 ;

Y 9 is selected from the group consisting of N—R 9f , CH—OR 9f , CH—NR 9f R 9i and C═CH—CO—R 9g ;

A 9 and B 9 are independently selected from 5- or 6-membered rings;

R 9a , R 9b , R 9c and R 9d are independently selected from the group consisting of H, halogen, CF 3 , NO 2 , NR 9i R 9j , CN, COOH, (CH 2 ) 0-2 -CONR 9i R 9j , C 1-6 alkyl, OH, O—C 1-6 alkyl, O-cyclopropyl, O—(CH 2 ) 2 —O—C 1-6 alkyl, O—(CH 2 ) 2 —NR 9i R 9j , O—CONHR 9i , CH 2 —Z 9 —R 9h , COR 9i , CR 9i R 9m R 9n , SR 9i , SO 2 R 9o , CR 9i NOR 9i , CR 9i NNR 9i R 9 j, a Q 9 -(CH 2 ) 2-9 CONHOH group, furan, thiophene, pyrrole, oxazole, thiazole, imidazole, pyrazole, isoxazole, isothiazole, 1,2,3-oxathiazole, 1,2,3-triazole, pyridine, pyridazine, pyrimidine, pyrazine, morpholine thiomorpholine, piperidine and pyrrolidine;

R 9e and R 9f are Q 9a -(CH 2 ) 2-9 CONHOH;

R 9g is NH—(CH 2 ) 2-9 CONHOH;

R 9h is a (CH 2 )P—R 9k group, wherein R 9k can be methyl or hydroxyl;

Z 9 is selected from the group consisting of O, NR 9L and S;

Q 9 is selected from the group consisting of a chemical bond, —O—, —S—, —NR 9L —, —NR 9i CO—, —CONR 9i —, —W 9 —, —COW 9 —, wherein W 9 is piperidine or pyrrolidine;

Q 9a is a bond or a —CO—;

R 9i and R 9j are independently H or a C 1-6 alkyl;

R 9L is H or R 9h

R 9m and R 9n can either be a fluorine atom or oxygen atoms linked together by an alkyl chain consisting of 2 or 3 CH 2 ; and

R 9o is a C 1-6 alkyl; provided that (1) only one (CH 2 ) 2-9 CONHOH is present in the molecule and (2) when X 9 is CO and A 9 and B 9 are both benzene then R 9c and R 9d cannot signify Q 9 -(CH 2 ) 2-9 CONHOH.

2 . The compound according to claim 1 , wherein Q comprises a bridged heterocycle,

comprises a first ring structure, said first ring structure attached via a covalent bond to said bridged heterocycle and J comprises a second ring structure, said second ring structure attached via a covalent bond to said bridged heterocycle, each of which is optionally substituted. In another preferred embodiment, L is a covalent bond.

3 . The method according to claim 1 or claim 2 , wherein

is a radical selected from the group consisting of

4 . The method according to any of claims 1 to 3 , wherein

is a radical selected from the group consisting of

wherein when

is

Q is attached via

and wherein when

is

Q is attached via D 1 -D 2 .

5 . The method according to any of claims 1 to 4 , wherein

is a radical selected from the group consisting of

6 . The method according to any of claims 1 to 5 , wherein Q is an optionally substituted moiety selected from the group consisting of

or where possible, an (R,R) or (S,S) enantiomer or a mixture of enantiomers, preferably an (R,R) enantiomer, more preferably an (S,S) enantiomer thereof, wherein G and G 1 are independently selected from —CH— and N; w1 and w2 are independently 0, 1, 2 or 3, provided that when both G and G 1 are N, then w1 and w2 are independently 1, 2 or 3; and wherein each ring structure includes a 0 (i.e., a bond), 1, 2 or 3 carbon bridge between two non-adjacent carbon atoms, provided that

is absent when U 1 is H, N(R 3 )(R 3a )—C 2 -C 4 alkyl- or R 3 —O—C 2 -C 4 alkyl-. Preferrably the ring size is 6, 7, 8 or 9 ring atoms, excluding any bridge atoms.

7 . The method according to any of claims 1 to 6 , wherein Q is an optionally substituted moiety selected from the group consisting of

or where possible, an (R,R) or (S,S) enantiomer or a mixture of enantiomers, preferably an (R,R) enantiomer, more preferably an (S,S) enantiomer thereof, wherein w1 and w2 are independently 0, 1, 2 or 3, provided that when the ring includes two N atoms, then w1 and w2 are independently 1, 2 or 3; and wherein each ring structure includes a 0 (i.e., a bond), 1, 2 or 3 carbon bridge between two non-adjacent carbon atoms, provided that

is absent when U 1 is H, N(R 3 )(R 3a )—C 2 -C 4 alkyl- or R 3 —O—C 2 -C 4 alkyl-.

8 . The method according to any of claims 1 to 5 , wherein Q is an optionally substituted moiety, selected from the group consisting of

or wherein possible, a (R,R) or (S,S) enantiomer or a mixture of enantiomers, preferably an (R,R) enantiomer, more preferably an (S,S) enantiomer thereof, wherein n is 1, 2 or 3, and wherein

is absent when Q is structure (a-1), (a-2), (a-3) or when U 1 is H, N(R 3 )(R 3a )—C 2 -C 4 alkyl- or R 3 —O—C 2 -C 4 alkyl-.

9 . The method according to any of claims 1 to 5 , wherein Q is an optionally substituted moiety selected from the group consisting of

or wherein possible, a (R,R) or (S,S) enantiomer or a mixture of enantiomers, preferably an (R,R) enantiomer, more preferably an (S,S) enantiomer thereof, wherein

is absent when U 1 is H, N(R 3 )(R 3a )—C 2 -C 4 alkyl- or R 3 —O—C 2 -C 4 alkyl-.

10 . The method according to claim 1 , wherein

Z is —N(R 1 )(OR 2 );

L is a covalent bond;

J is selected from the group consisting of a covalent bond, ═CH—, —C 1 -C 8 alkyl-, —C 0 -C 3 alkyl-C 1 -C 8 heteroalkyl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C 2 -C 8 alkenyl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C 2 -C 8 alkynyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 heteroalkyl-, —C 0 -C 6 alkyl-cycloalkyl-C 0 -C 6 alkyl-, —C 4 -C 6 heterocyclyl-aryl-C 0 -C 6 alkyl-, —C 4 -C 6 heterocyclyl-aryl-C 0 -C 6 heteroalkyl-, —C 0 -C 6 alkyl-C 4 -C 6 heterocyclyl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 heteroalkyl-, —C 4 -C 6 heterocyclyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkynyl-, —C 0 -C 6 alkyl-heteroaryl-C 2 -C 6 alkynyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkynyl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-heteroaryl-C 2 -C 6 alkenyl-, —C 2 -C 6 alkenyl-aryl-C 0 -C 6 alkyl-, —C 2 -C 6 alkenyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkylaryl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkylaryl-heteroaryl-C 0 -C 6 alkyl- and —C 0 -C 6 alkyl-C 3 -C 6 cycloalkyl-C 0 -C 6 alkyl-, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, heterocyclyl, and cycloalkyl moiety is optionally substituted, wherein when J is ═CH—, Q is a covalent bond and B is attached through a carbon sp 2 to J;

Q is a moiety selected from the group consisting of

or an optionally substituted (R,R) or (S,S) enantiomer or a mixture of enantiomers, preferably an (R,R) enantiomer, more preferably an (S,S) enantiomer thereof, wherein n is 0, 1, 2 or 3; and

U is selected from the group consisting of —C 0 -C 8 alkyl-C(O)—C 0 -C 3 alkyl-, —C 1 -C 8 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-O—C(O)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—C(S)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-O—C(S)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—S(O) 2 —C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-heterocyclyl-C 0 -C 3 alkyl-, a covalent bond and —O—C 2 -C 4 alkyl-; and

U 1 is selected from the group consisting of H, —C 0 -C 8 alkyl-C(O)—C 0 -C 3 alkyl-, —C 1 -C 8 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-O—C(O)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—C(S)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-O—C(S)—C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-N(R 3 )—S(O) 2 —C 0 -C 3 alkyl-, —C 0 -C 8 alkyl-heterocyclyl-C 0 -C 3 alkyl-, a covalent bond, (R 3 )(R 3a )N—C 2 -C 4 alkyl-, —O—C 2 -C 4 alkyl-, and R 3 —O—C 2 -C 4 alkyl-;

wherein

is absent when Q is structure (a-1), (a-2), (a-3) or when U 1 is H, N(R 3 )(R 3a )—C 2 -C 4 alkyl- or R 3 —O—C 2 -C 4 alkyl-.

11 . The method according to any of claim 10 , wherein J is selected from the group consisting of a —C 0 -C 3 alkyl-C 1 -C 8 heteroalkyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 heteroalkyl-, —C 0 -C 6 alkyl-cycloalkyl-C 0 -C 6 alkyl-, —C 4 -C 6 heterocyclyl-aryl-C 0 -C 6 alkyl-, —C 4 -C 6 heterocyclyl-aryl-C 0 -C 6 heteroalkyl-, —C 0 -C 6 alkyl-C 4 -C 6 heterocyclyl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 heteroalkyl-, —C 4 -C 6 heterocyclyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkynyl-, —C 0 -C 6 alkyl-heteroaryl-C 2 -C 6 alkynyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkynyl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-heteroaryl-C 2 -C 6 alkenyl-, —C 2 -C 6 alkenyl-aryl-C 0 -C 6 alkyl-, —C 2 -C 6 alkenyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkylaryl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkylaryl-heteroaryl-C 0 -C 6 alkyl- and —C 0 -C 6 alkyl-C 3 -C 6 cycloalkyl-C 0 -C 6 alkyl-, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, heterocyclyl, and cycloalkyl moiety is optionally substituted.

12 . The method according to claim 11 , wherein J is —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl- or —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl-.

13 . The method according to any of claims 10 to 12 , wherein Q is selected from the group consisting of

14 . The method according to any of claims 10 to 13 , wherein U and U 1 are a covalent bond.

15 . The method according to any of claims 10 to 13 , wherein U and U 1 are —C(O)—.

16 . The method according to any of claims 10 to 13 , wherein U is —C(O)—O—C 0 -C 3 alkyl-.

17 . The method according to any of claims 10 to 13 , wherein U 1 is —C 0 -C 3 alkyl-O—C(O)—.

18 . The method according to claim 1 , wherein

J is selected from the group consisting of —C 1 -C 8 alkyl-, —C 0 -C 6 alkyl-aryl-C 0 -C 3 alkyl-C 2 alkenyl-C 0 -C 3 alkyl, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 3 alkyl-C 2 alkenyl-C 0 -C 3 alkyl, —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl- and —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl-, wherein each is optionally substituted;

Q is selected from the group consisting of a covalent bond, —C 1 -C 8 alkyl-, ═N—O—, —C 0 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-(CR 3 ═CR 3 ) 1-2 -C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-(C≡C) 1-2 —C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-, wherein each alkyl and heterocyclyl moiety is optionally substituted;

or

Q is selected from the group consisting of:

wherein

U 1 is selected from the group consisting of —C 0 -C 8 alkyl-C(O)—C 0 -C 3 alkyl-, —C 1 -C 8 alkyl-, —C 0 -C 8 alkyl-O—C(O)—C 0 -C 3 alkyl- and a covalent bond;

wherein, when B is attached to Q via a N in B, then Q is selected from the group consisting of a covalent bond, —C(O)—C 1 -C 3 alkyl-O—, —C 1 -C 8 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-, —C 2 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 1 -C 6 alkyl-(CR 3 ═CR 3 ) 1-2 -C 0 -C 6 alkyl- and —C 1 -C 6 alkyl-(C≡C) 1-2 —C 0 -C 6 alkyl-, wherein each alkyl moiety is optionally substituted;

provided that

is absent when Q is

and

is selected from the group consisting of hydrogen, aryl, cycloalkyl, heterocyclyl, heteroaryl, heteroarylalkyl, aryl-alkyl-, (heteroaryl) 2 -CH—C 0 -C 6 alkyl- and (aryl) 2 -CH—C 0 -C 6 alkyl-, each of which is optionally substituted, provided that Q is

or

is a radical selected from the group consisting of

19 . The method according to claim 18 , wherein

is

20 . The method according to claim 1 , wherein the compound has a structure selected from the group consisting of

wherein k is 0 or 3.

21 . The method according to any of claims 1 to 9 , wherein Z is —NR 1 OR 2 , R 1 and R 2 are H, and L is a covalent bond.

22 . The method according to any of claims 1 to 9 , wherein Z is H and L is —N(OH).

23 . The method according to any of claims 1 to 9 , wherein J is selected from the group consisting of —C 1 -C 8 alkyl-, —C 0 -C 3 alkyl-C 1 -C 8 alkenyl-C 0 -C 3 -alkyl, —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkenyl, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl- and —C 0 -C 6 alkyl-heterocyclyl-heteroaryl-C 0 -C 6 alkyl-.

24 . The method according to any of claims 1 to 9 , wherein J is selected from the group consisting of

25 . The method according to any of claims 1 to 5 , wherein Q is selected from the group consisting of a covalent bond, —C 1 -C 8 alkyl-, ═N—O—, —C 0 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-(CR 3 ═CR 3 ) 1-2 -C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-(C≡C) 1-2 -C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)-alkenyl-C 0 -C 4 alkyl-, —C 0 -C 6 alkyl-C(O)—N(R 3 )—C 0 -C 4 alkyl-, —C 0 -C 6 alkyl-SO 2 —N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—SO 2 —C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—S(O) 2 —N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S(O) 2 —C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C═N—O—C 0 -C 3 alkyl-, -heterocyclyl-C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —SO 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C(O)—C 0 -C 6 alkyl-bridged heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —O—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —O—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—S(O) 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-SO 2 —N(R 3 )—, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—N(R 3 )— and —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—O—, wherein each alkyl, heterocyclyl and alkenyl moiety is optionally substituted.

26 . The method according to any of claims 1 to 5 , wherein Q is selected from the group consisting of covalent bond, ═N—O—, —C 1 -C 8 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)NR 3 —C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl- and —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 -alkyl.

27 . The method according to any of claims 1 to 5 , wherein Q is selected from the group consisting of

28 . The method according to claim 1 , wherein

is selected from the group consisting of aryl, aryl-alkyl-, heteroaryl, heteroaryl-alkyl-, (aryl) 2 -CH—C 0 -C 6 alkyl-, (arylXheteroaryl)CH—C 0 -C 6 alkyl-, (heteroaryl) 2 CH—C 0 -C 6 alkyl- and (aryl) 2 -CH—C 0 -C 6 alkyl-C(O)—, —wherein each group is optionally substituted with 1, 2, 3 or 4 substituents independently selected from the group consisting of hydroxy, amino, halo, C 1 -C 6 alkyl, nitro, cyano, C 2 -C 6 alkoxy, C 1 -C 6 alkylamino and CF 3 .

29 . The method according to claim 1 , wherein

is selected from the group consisting of

30 . The method according to any of claims 1 to 29 , wherein each alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, heterocyclyl, and cycloalkyl moiety of J is optionally substituted with from one to three substituents independently selected from the group consisting of alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl.

31 . The method according to any of claims 1 to 5 , wherein Q is selected from the group consisting of a covalent bond, —C 1 -C 6 alkyl-, ═N—O—, —C 0 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-(CR 3 ═CR 3 ) 1-2 -C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-(C≡C) 1-2 -C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)-alkenyl-C 0 -C 4 alkyl-, —C 0 -C 6 alkyl-C(O)—N(R 3 )—C 0 -C 4 alkyl-, —C 0 -C 6 alkyl-SO 2 —N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—SO 2 —C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—S(O) 2 —N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S(O)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-S(O) 2 —C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C═N—O—C 0 -C 3 alkyl-, -heterocyclyl-C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —SO 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C(O)—C 0 -C 6 alkyl-bridged heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —O—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —O—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—S(O) 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-SO 2 —N(R 3 )—, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—N(R 3 )— and —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—O—, wherein each alkyl, heterocyclyl and alkenyl moiety is optionally substituted with from one to three substituents independently selected from the group consisting of alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl.

32 . The method according to any of claims 1 to 5 , wherein Q is an optionally substituted (1R,4R) or (1S,4S) 2,5-diazabicyclo[2.2.1]heptane enantiomer or a mixture of enantiomers, preferably an (1R,4R) enantiomer, more preferably an (1S,4S) enantiomer, selected from the group consisting of

or

Q is

is absent; or

Q is

is H.

33 . The method according to claim 1 , wherein when

is attached to Q via a N in

then Q is selected from the group consisting of —C 1 -C 8 alkyl-, —C 2 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-, —C 2 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 1 -C 6 alkyl-(CR 3 ═CR 3 ) 1-2 —C 0 -C 6 alkyl-, —C 1 -C 6 alkyl-(C≡C) 1-2 —C 0 -C 6 alkyl-, —C 2 -C 6 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl, —C 2 -C 6 alkyl-N(R 3 )—C(O)-alkenyl-C 0 -C 3 alkyl, —C 0 -C 6 alkyl-C(O)—N(R 3 )—C 0 -C 4 alkyl-, —C(O)—O—C 0 -C 4 alkyl, —C 0 -C 6 alkyl-S(O) 2 —N(R 3 )—C 0 -C 3 alkyl, —C 2 -C 6 alkyl-N(R 3 )—S(O) 2 —C 0 -C 3 alkyl, —C 2 -C 3 alkyl-N(R 3 )—S(O) 2 —N(R 3 )—C 0 -C 3 alkyl-, —C 2 -C 6 alkyl-S—C 0 -C 3 alkyl, —C 2 -C 6 alkyl-S(O)—C 0 -C 3 alkyl, —C 0 -C 6 alkyl-S(O) 2 —C 0 -C 3 alkyl, —C 2 -C 6 alkyl-N(R 3 )—C(O)—N(R 3 )—C 0 -C 3 alkyl, —C 2 -C 3 alkyl-C═N—O—C 0 -C 3 alkyl, —SO 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —O—C(O)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —O—C(S)—C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —N(R 3 )—S(O) 2 —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-S(O 2 )—N(R 3 )—, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—N(R 3 )— and —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-C(O)—O—, wherein each alkyl, heterocyclyl and alkenyl moiety is optionally substituted with from one to three substituents independently selected the group consisting of alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl, and wherein the heterocyclyl moiety optionally has a bridge of —(CH 2 ) 0-3 —.

34 . The method according to any of claims 1 to 33 , wherein each R 3 is independently selected from the group consisting of —H, alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl, heteroaryl and a covalent bond, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted with from one to three substituents independently selected from the group consisting of alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl.

35 . The method according to any of claims 1 to 5 , wherein Q-J-L is selected from the group consisting of —C 3 -C 8 alkyl-, —C(O)—C 3 -C 8 alkyl-, —C 0 -C 3 alkyl-O—C 3 -C 8 alkyl-, —C 0 -C 3 alkyl-C 1 -C 4 alkenyl-C 0 -C 3 alkyl-, ═N—O—C 1 -C 8 alkyl-, ═N—O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, ═N—O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkenyl-, ═N—O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkynyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkenyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkynyl-, —C 0 -C 3 alkyl-aryl-, —C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl-, —C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl-, —C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 1 -C 3 alkyl-heteroaryl-C 1 -C 3 alkenyl-, —C 1 -C 3 alkyl-heteroaryl-C 1 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 2 -C 4 alkyl-O—C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl- and —C 2 -C 4 alkyl-O—C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, wherein each alkyl, alkenyl, aryl, alkynyl, heteroaryl and heterocyclyl moiety is optionally substituted with from one to three substituents independently selected from the group consisting of alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl.

36 . The method according to claim 1 , wherein

is selected from the group consisting of hydrogen, aryl, aryl-alkyl-, heteroaryl, heteroaryl-alkyl-, (aryl) 2 -CH—C 0 -C 6 alkyl-, (aryl)(heteroaryl)CH—C 0 -C 6 alkyl-, (heteroaryl) 2 CH—C 0 -C 6 alkyl- and (aryl) 2 -CH—C 0 -C 6 alkyl-C(O)—, each of which is optionally substituted with from one to three substituents independently selected from the group consisting of alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl, provided that variable n of Q is 0, 1 or 3.

37 . The method according to claim 1 , wherein

is selected from the group consisting of structures (b-1) to (b-121) and Q-J-L taken together is selected from the group consisting of —C 3 -C 8 alkyl-, —C(O)—C 3 -C 8 alkyl-, —C 0 -C 3 alkyl-O—C 3 -C 8 alkyl-, —C 0 -C 3 alkyl-C 1 -C 4 alkenyl-C 0 -C 3 alkyl-, ═N—O—C 1 -C 8 alkyl-, ═N—O—C 0 -C 3 alkyl-ayl-C 0 -C 3 alkyl-, ═N—O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkenyl-, ═N—O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkynyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkenyl-, ═N—O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkynyl-, —C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl-, —C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl-, —C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-heteroaryl-C 1 -C 3 alkenyl-, —C 0 -C 3 alkyl-heteroaryl-C 1 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-ayl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)C 3 alkyl-ayl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-aryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-C(O)—N(R 3 )—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-O—C(O)— heterocyclyl-C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 0 -C 3 alkyl-heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-O—C(O)— heterocyclyl-C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 0 -C 3 alkyl-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 0 -C 3 alkyl-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-N(R 3 )—C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 3 alkyl-O—C(O)-heterocyclyl-C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-, —C 2 -C 4 alky-O—C 0 -C 3 alkyl-aryl-C 0 -C 3 alkyl-, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-C 2 -C 4 alkenyl, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-aryl-C 2 -C 4 alkynyl, —C 2 -C 4 alkyl-O—C 0 -C 3 alkyl-heteroaryl-C 0 -C 3 alkyl, —C 2 -C 4 alkyl-O—C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkenyl-, —C 2 -C 4 alkyl-O—C 1 -C 3 alkyl-heteroaryl-C 2 -C 3 alkynyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-N(R 3 )-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U—N(R 3 )-bridged heterocyclyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-N(R 3 )-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U—N(R 3 )-bridged heterocyclyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-N(R 3 )-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U—N(R 3 )-bridged heterocyclyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U-bridged heterocyclyl-N(R 3 )-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-U—N(R 3 )-bridged heterocyclyl-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-U-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-N(R 3 )-bridged heterocyclyl-U-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-N(R 3 )—U-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-U-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-N(R 3 )-bridged heterocyclyl-U-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-N(R 3 )—U-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-U-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-N(R 3 )-bridged heterocyclyl-U-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-N(R 3 )—U-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-bridged heterocyclyl-U-heteroaryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-N(R 3 )-bridged heterocyclyl-U-heteroaryl-C 2 -C 6 alkenyl-, and —C 0 -C 6 alkyl-bridged heterocyclyl-N(R 3 )—U-heteroaryl-C 2 -C 6 alkenyl-, wherein each alkyl, alkenyl, aryl, alkynyl, heteroaryl and heterocyclyl moiety is optionally substituted; and wherein the bridge is methylene or propylene.

38 . The method according to claim 1 , wherein B-Q-J-L- are taken together, wherein each such B-Q-J-L group is optionally substituted with up to 4 substituents independently selected from the group consisting of hydroxy, amino, halo, C 1 -C 6 alkyl, nitro, cyano, C 2 -C 6 alkoxy, C 1 -C 6 amino and CF 3 , heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl and alkylheteroaryl.

39 . The method according to any of claims 1 to 38 , wherein each R 4 is independently selected from the group consisting of —H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl-R 3 , —C 0 -C 6 alkyl-OR 3 , —C 0 -C 6 alkyl-OR 1 , —C 0 -C 6 alkyl-C(O)—OR 3 , —C 0 -C 6 alkyl-C(O)NR 3 R 3a , —CH═CH—C(O)—OR 3 , —CH═CH—C(O)—N(R 3 )(R 3a ), —N(R 3 )—C(O)—CF 3 , —N(R 3 )—C 2 -C 6 alkyl-N(R 3 )(R 3a ), —C 0 -C 6 alkyl-N(R 3 )(R 3a ), —N(R 3 )—C(O)—C 1 -C 6 alky-R 3 , —N(R 3 )—S(O) 2 —C 1 -C 6 alkyl-R 3 , —S(O) 2 —N(R 3 )R 3a , —O—C 2 -C 6 alkyl-N(R 3 )(R 3a ), —S—R 3 , —S(O)—C 1 -C 6 alkyl-R 3 , —S(O) 2 —C 1 -C 6 alkyl-R 3 , C 3 -C 6 cycloalkyl, heterocyclyl, C 4 -C 7 heterocyclyl-R 3 , —O—C 2 -C 4 alkyl-heterocyclyl, —O-heterocyclyl-C(O)—OR 3 , —O—C 0 -C 4 alkyl-aryl, —O—C 0 -C 4 alkyl-heteroaryl, —O—C(O)—NR 3 -C 0 -C 4 alkyl-aryl, —O—C(O)—NR 3 -C 0 -C 4 alkyl-heteroaryl, —O—C 0 -C 4 alkyl-heterocyclylaryl, —O—C 0 -C 4 alkyl-heterocyclyl-heteroaryl, —N(R 3 )—C 2 -C 4 alkyl-heterocyclyl, —N(R 3 )C(O)N(R 3 )—C 0 -C 4 alkyl-heterocyclyl-R 3 , —C 0 -C 4 alkyl-OC(O)—R 3 , —C 0 -C 4 alkyl-N(R 3 )C(O)—O—R 3 , —C 0 -C 4 alkyl-heterocyclyl-C(O)—O—R 3 , —N(R 3 )—C 2 -C 4 alkyl-heterocyclyl, F, Cl, Br, I, NO 2 , —CF 3 , —SO 3 H, —CN, —C 1 -C 6 alkylaryl, aryl, heteroaryl, —C 1 -C 6 alkylheteroaryl, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moeity of the aformentioned R 4 is optionally substituted with from one to three substituents independently selected from the group consisting of alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl.

40 . The method according to any of claims 1 to 39 , wherein each R 3a is independently selected from the group consisting of —H, alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl, covalent bond, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted with from one to three substituents independently selected from the group consisting of alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl.

41 . The method according to any of claims 1 to 5 , wherein Q is selected from the group consisting of

or an optionally substituted (R,R) or (S,S) enantiomer or a mixture of enantiomers, preferably an (R,R) enantiomer, more preferably an (S,S) enantiomer thereof, each of which is optionally substituted with a substituent selected from the group consisting of halo, alkyl and aryl.

42 . The method according to claim 1 , wherein

is selected from the group consisting of

wherein

-M 1 -M 2 - is —CH═CH— or —CH 2 —CH 2 —;

A is selected from the group consisting of N, C(R 4 ) and CH;

Z is —NHOH;

L is covalent bond;

J is selected from the group consisting of —C 1 -C 8 alkyl-, —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl- and —CH═; and

Q is selected from the group consisting of covalent bond, ═N—O—, —C 0 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl- and —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-.

43 . The method according to claim 1 , wherein

is further selected from the group consisting of

44 . The method according to claim 1 , wherein

is selected from the group consisting of

and

Q is —C 0 -C 6 alkyl-.

45 . The method according to claim 1 , wherein

is optionally substituted

W is —CH═CH— or —CH 2 —CH 2 —;

Y is selected from the group consisting of N, C(R 4 ) and CH;

Z is —NHOH;

L is covalent bond;

J is selected from the group consisting of —C 1 -C 8 alkyl-, —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkenyl-, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl- and —CH═; and

Q is selected from the group consisting of covalent bond, ═N—O—, —C 0 -C 6 alkyl-N(R 3 )—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-N(R 3 )—C(O)—C 0 -C 3 alkyl- and —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl-.

46 . The method according to claim 1 , wherein

is selected from the group consisting of

each of which is optionally substituted on a phenyl ring with one or two R4;

Z is —NR 1 OR 2 or H;

R 1 and R 2 are —H;

L is covalent bond or —N(OH)—;

J is —C 1 -C 8 alkyl-, —C 0 -C 6 alkyl-aryl-C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl-, —C 0 -C 3 alkyl-C 2 -C 6 alkenyl-C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkenyl- and —C 2 -C 6 alkenyl-aryl-C 0 -C 6 alkyl-;

Q is selected from the group consisting of covalent bond, —C 1 -C 3 alkyl-(C≡C)—C 0 -C 3 alkyl, —C 0 -C 6 alkyl-, —C 1 -C 3 alkyl-(CH═CH)—C 0 -C 3 alkyl-, —C 2 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 2 -C 6 alkyl-C(O)—C 0 -C 3 alkyl- and —C 2 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl-; or

Q is selected from the group consisting of a covalent bond, —C 1 -C 3 alkyl-(C≡C)—C 0 -C 3 alkyl, —C 0 -C 6 alkyl-, —C 1 -C 3 alkyl-(CH═CH)—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl-, —C 0 -C 6 alkyl-C(O)—C 0 -C 3 alkyl- and —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl- when

is

and

R 3 is H or cycloalkyl.

47 . The method according to claim 1 , wherein

is selected from the group consisting of (aryl) 2 -CH—C 0 -C 6 alkyl-, (aryl) 2 -C 1 -C 6 alkyl- and (heteroaryl) 2 -C 1 -C 6 alkyl-, wherein each aryl, alkyl and heteroaryl moiety is optionally substituted;

Z is NHOH;

Q is selected from the group consisting of —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl-, ═N—O—, —C 0 -C 6 alkyl-heterocyclyl-C 0 -C 3 alkyl and —C 0 -C 6 alkyl-O—C 0 -C 3 alkyl;

J is —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl; and

L is a covalent bond.

48 . The method according to claim 1 , wherein

is selected from the group consisting of aryl and (aryl) 2 -alkyl, each of which is optionally substituted and H;

Q is selected from the group consisting of —C 0 -C 6 alkyl-bridged heterocyclyl-C 0 -C 3 alkyl- and

J is —C 0 -C 6 alkyl-heteroaryl-C 0 -C 6 alkyl;

L is a covalent bond; and

Z is NHOH.

49 . The method according to claim 1 , wherein

is

Z is —NHOH;

R 3 is H or alkyl;

L is covalent bond;

J is —C 1 -C 8 alkyl- or —C 0 -C 3 alkyl-C 1 -C 8 alkenyl-C 0 -C 3 alkyl-; and

Q is covalent bond.

50 . The method according to claim 1 , wherein

is

Z is —NHOH;

L is a covalent bond;

J is —C 1 -C 8 alkyl- or —C 0 -C 6 alkyl-aryl-C 2 -C 6 alkenyl-; and

Q is a covalent bond.

51 . The method according to claim 1 , wherein the selected from one of the following structures:

wherein A is N or —CH═.

52 . A method for treating a cognitive disorder or deficit comprising administering an effective amount of the compound of Formula (II):

and pharmaceutically acceptable salts thereof, wherein

Z is selected from the group consisting of —N(R 1 )OR 2 and H;

L is selected from the group consisting of a covalent bond and —N(OR 2 )—;

wherein, when L is —N(OR 2 )—, then Z is H; and

wherein, when Z is H, then L is —N(OR 2 )—;

R 1 and R 2 are independently selected from the group consisting of —H and C 1 -C 6 alkyl;

W is nitrogen or carbon;

D 1a -D 2a is selected from the group consisting of

wherein, * represents the point of attachment to Q;

D 3 is independently selected from the group consisting of —C(R 55 )(R 66 )—, —C(R 55 )(OH)—, —C(O)—, —O—, —N(R 77 )— and —S(O) 0-2 -;

and are independently selected from the group consisting of phenyl, heteroaryl and heterocyclyl, wherein each phenyl, heteroaryl and heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —CF 3 , —OCF 3 , —NO 2 , —CN, —C 1 -C 6 alkyl, —C 1 -C 6 alkoxyl, —O—C 2 -C 6 alkyl-O—R 53 , —O—R 53 , —C 0 -C 6 alkyl-S(O) 0-2 —R 3 , —C 0 -C 6 alkyl-C(O)—R 53 , —C 0 -C 6 alkyl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)—R 53 , —C 0 -C 6 alkyl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 S(O) 2 —R 53 , —C 0 -C 6 alkyl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)O—R 53 , —C 0 -C 6 alkyl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-C(O)O—R 53 , —C 0 -C 6 alkyl-OC(O)—R 53 , —C 0 -C 6 alkyl-aryl, —C 0 -C 6 alkyl-heteroaryl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, —C 0 -C 6 alkyl-heterocyclyl, —C 0 -C 6 alkyl-NR 50 R 51 , —O—C 2 -C 6 alkyl-NR 50 R 51 , —NR 53 —C 2 -C 6 alkyl-NR 50 R 51 and —O-heterocyclyl-R 53 ;

R 44 is independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl and —C 0 -C 4 alkyl-heterocyclyl;

R 50 and R 51 are independently selected from the group consisting of H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, wherein each alkyl and cycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

or

R 50 and R 51 , together with the N atom to which they are attached, optionally form a 3-10 membered heterocyclic ring, wherein the heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 52 is independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, wherein each alkyl and cycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 53 is independently selected from the group consisting of —C 1 -C 6 alkyl, —C 0 -C 4 alkyl-C 3 -C 7 cycloalkyl, —C 0 -C 4 alkyl-aryl, —C 0 -C 4 alkyl-heteroaryl and —C 0 -C 4 alkyl-heterocyclyl, wherein each alkyl, aryl, heteroaryl and heterocyclyl is optionally substituted with one or three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 55 and R 66 are independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 1 -C 6 alkoxyl, —C 0 -C 4 alkyl-C 3 -C 7 cycloalkyl and —C 0 -C 4 alkyl-heterocyclyl;

or

R 55 and R 66 , together with the atom to which they are attached, optionally form a 3-7 membered cycloalkyl or heterocyclic ring, wherein each cycloalkyl and heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 77 is independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 1 -C 6 heteroalkyl, —C 3 -C 7 cycloalkyl, —C(O)—R 53 , —C(O)O—R 53 , -cycloalkyl, —C 1 -C 4 alkyl-cycloalkyl, phenyl, —C 1 -C 4 alkyl-phenyl, -heterocyclyl, —C 1 -C 4 alkyl-heterocyclyl and —C 2 -C 6 alkyl-NR 88 R 99 , wherein each alkyl and heteroalkyl is optionally substituted with one or three substituents independently selected from the group consisting of F, —OH and oxo, wherein each phenyl, cycloalkyl and heterocyclyl is optionally substituted with one or two substituents independently selected from the group consisting of halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 ;

or R 77 together with the N to which it is attached may form a ring with

wherein the ring is a 5-7 membered heterocyclic ring, and

R 88 and R 99 are independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl and —C 0 -C 4 alkyl-C 3 -C 7 cycloalkyl, wherein each cycloalkyl and alkyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 6 alkyl-aryl;

or

R 88 and R 99 , together with the N atom to which they are attached, optionally form a 3-10 membered heterocyclic ring, wherein an heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —OH, amino or —CN

53 . The method according to claim 52 , wherein

J-Q is selected from the group consisting of —C 1 -C 9 alkyl, —C 1 -C 9 heteroalkyl, phenyl, aryl, heteroaryl, —C 1 -C 4 alkyl-phenyl, —C 1 -C 4 alkyl-aryl, —C 1 -C 4 alkyl-heteroaryl, —NR 33 aryl, —NR 33 —C 1 -C 4 alkyl-aryl, —NR 33 heteroaryl and NR 33 —C 1 -C 4 alkyl-heteroaryl, wherein each alkyl and heteroalkyl is optionally substituted with one or three substituents independently selected from the group consisting of F, —OH and oxo, and wherein each phenyl, aryl and heteroaryl is optionally substituted with one or two substituents independently selected from the group consisting of halo, —OH, —OR 53 , —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 6 alkyl, —CN, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 , wherein R 33 is independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl and —C 0 -C 4 alkyl-phenyl, wherein each phenyl and cycloalkyl is optionally substituted with one or three substituents independently selected from the group consisting of halo, —OH, —NO 2 , —CF 3 , —OCF 3 , amino, —N(C 1 -C 6 alkyl) 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 3 , —C 1 -C 4 alkoxyl-CN, —O—C 2 alkyl-O—CH 3 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 or —C 1 -C 4 alkyl.

54 . The method according to claim 52 or claim 53 , wherein

55 . The method according to any of claims 52 to 54 , wherein J-Q is selected from the group consisting of 5- or 6-membered heteroaryl.

56 . The method according to claim 52 , wherein the compound has Formula (III):

wherein

R 140 is selected from the group consisting of H, —OH, halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 3 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 .

57 . The method according to claim 56 , wherein

D 1a -D 2a is selected from the group consisting of

58 . The method according to claim 56 , wherein

D 1a -D 2a is

59 . The method according to claim 56 , wherein

D 1a -D 2a is

and

D 3 is selected from the group consisting of —C(R 55 )(R 66 )—, —C(R 55 )(OH)—, —C(O)—, —O—, —N(R 77 )— and —S(O) 0-2 .

60 . The method according to claim 56 , wherein

D 1a -D 2a is

and

D 3 is —N(R 77 )—.

61 . The method according to claim 56 , wherein

D 1a -D 2a is

and D 3 is —O—.

62 . The method according to claim 56 , wherein

D 1a -D 2a is

D 3 is —O—; and

are independently selected from the group consisting of phenyl, pyridyl, pyrimidyl, thienyl, pyrazolyl, thiazyl and oxazyl.

63 . The method according to claim 56 , wherein

D 1a -D 2a is

D 3 is —O—; and

and are independently selected from the group consisting of phenyl, pyridyl, pyrimidyl, thienyl, pyrazolyl, thiazyl and oxazyl, wherein at least one of

is phenyl, wherein the phenyl, pyridyl, pyrimidyl, thienyl, pyrazolyl, thiazyl and oxazyl are independently optionally substituted.

64 . The method according to claim 56 , wherein

D 1a -D 2a is

D 3 is —N(R 77 )—; and

and are independently selected from the group consisting of phenyl, pyridyl, pyrimidyl and thienyl.

65 . The method according to claim 56 , wherein

D 1a -D 2a is

D 3 is —N(R 77 )—; and

and are independently selected from the group consisting of phenyl, pyridyl, pyrimidyl and thienyl, wherein at least one of and

is phenyl, wherein said phenyl, pyridyl, pyrimidyl and thienyl are independently optionally substituted.

66 . The method according to claim 56 , wherein the compound has Formula (IV):

wherein

R 140 is selected from the group consisting of H, —OH, halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 ;

xa and xb denote numbers that are each independently selected from 0, 1 and 2; and

R 150 and R 160 are independently selected from the group consisting of H, halo, —CN, —CF 3 , —OCF 3 , —C 1 -C 6 alkyl, —C 1 -C 6 alkoxyl, —O—C 2 -C 6 alkyl-O—R 53 , —OR 53 , —C 0 -C 6 alkyl-S(O) 0-2 —R 53 , —C 0 -C 6 alkyl-C(O)—R 53 , —C 0 -C 6 alkyl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)—R 53 , —C 0 -C 6 alkyl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 S(O) 2 —R 53 , —C 0 -C 6 alkyl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)O—R 53 , —C 0 -C 6 alkyl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-C(O)O—R 53 , —C 0 -C 6 alkyl-OC(O)—R 53 , —C 0 -C 6 alkyl-aryl, —C 0 -C 6 alkyl-heteroaryl, —C 0 -C 6 alkyl-cycloalkyl, —C 0 -C 6 alkyl-heterocyclyl, —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 , —O—C 2 -C 6 alkyl-NR 50 R 51 , —NR 53 —C 2 -C 6 alkyl-NR 50 R 51 and —O-heterocyclyl-R 53 , wherein each alkyl and heteroalkyl is optionally substituted with one or three substituents independently selected from the group consisting of F, —OH and oxo, and wherein each aryl, heteroaryl, cycloalkyl and heterocyclyl is optionally substituted with one or two substituents independently selected from the group consisting of halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 ;

R 50 and R 51 are independently selected from the group consisting of H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, wherein each alkyl and cycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

or

R 50 and R 51 , together with the N atom to which they are attached, optionally form a 3-10 membered heterocyclic ring, wherein the heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 52 is independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, wherein each alkyl and cycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 53 is independently selected from the group consisting of —C 1 -C 6 alkyl, —C 0 -C 4 alkyl-C 3 -C 7 cycloalkyl, —C 0 -C 4 alkyl-aryl, —C 0 -C 4 alkyl-heteroaryl and —C 0 -C 4 alkyl-heterocyclyl, wherein each alkyl, aryl, heteroaryl and heterocyclyl is optionally substituted with one or three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl.

67 . The method according to claim 66 , wherein the compound has Formula (V):

wherein

R 140 is selected from the group consisting of H, —OH, halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 ;

xb denotes a number selected from 0, 1 and 2; and

R 150 and R 160 are independently selected from the group consisting of H, halo, —CN, —CF 3 , —OCF 3 , —C 1 -C 6 alkyl, —C 1 -C 6 alkoxyl, —O—C 2 -C 6 alkyl-O—R 53 , —OR 53 , —C 0 -C 6 alkyl-S(O) 0-2 —R 3 , —C 0 -C 6 alkyl-C(O)—R 53 , —C 0 -C 6 alkyl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)—R 53 , —C 0 -C 6 alkyl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 S(O) 2 —R 53 , —C 0 -C 6 alkyl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)O—R 53 , —C 0 -C 6 alkyl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-C(O)O—R 53 , —C 0 -C 6 alkyl-OC(O)—R 53 , —C 0 -C 6 alkyl-aryl, —C 0 -C 6 alkyl-heteroaryl, —C 0 -C 6 alkyl-cycloalkyl, —C 0 -C 6 alkyl-heterocyclyl, —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 , —O—C 2 -C 6 alkyl-NR 50 R 51 , —NR 53 —C 2 -C 6 alkyl-NR 50 R 51 and —O-heterocyclyl-R 53 , wherein each alkyl and heteroalkyl is optionally substituted with one or three substituents independently selected from the group consisting of F, —OH and oxo, and wherein each aryl, heteroaryl, cycloalkyl and heterocyclyl is optionally substituted with one or two substituents independently selected from the group consisting of halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 ;

xc is 0 or 1; and

R 170 is selected from the group consisting of H, halo, —CN, —CF 3 , —OCF 3 , —C 1 -C 6 alkyl, —C 1 -C 6 alkoxyl, —O—C 2 -C 6 alkyl-O—R 3 , —OR 53 , —C 0 -C 6 alkyl-S(O) 0-2 —R 3 , —C 0 -C 6 alkyl-C(O)—R 53 , —C 0 -C 6 alkyl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)—R 53 , —C 0 -C 6 alkyl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 S(O) 2 —R 53 , —C 0 -C 6 alkyl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)O—R 53 , —C 0 -C 6 alkyl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-C(O)O—R 53 , —C 0 -C 6 alkyl-OC(O)—R 53 , —C 0 -C 6 alkyl-aryl, —C 0 -C 6 alkyl-heteroaryl, —C 0 -C 6 alkyl-cycloalkyl, —C 0 -C 6 alkyl-heterocyclyl, —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 , —O—C 2 -C 6 alkyl-NR 50 R 51 , —NR 53 —C 2 -C 6 alkyl-NR 50 R 51 and —O-heterocyclyl-R 53 , wherein each alkyl and heteroalkyl is optionally substituted with one or three substituents independently selected from the group consisting of F, —OH and oxo, wherein each aryl, heteroaryl, cycloalkyl and heterocyclyl is optionally substituted with one or two substituents independently selected from the group consisting of halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2

R 50 and R 51 are independently selected from the group consisting of H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, wherein each alkyl and cycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

or

R 50 and R 51 , together with the N atom to which they are attached, optionally form a 3-10 membered heterocyclic ring, wherein the heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 52 is independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, wherein each alkyl and cycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 53 is independently selected from the group consisting of —C 1 -C 6 alkyl, —C 0 -C 4 alkyl-C 3 -C 7 cycloalkyl, —C 0 -C 4 alkyl-aryl, —C 0 -C 4 alkyl-heteroaryl and —C 0 -C 4 alkyl-heterocyclyl, wherein each alkyl, aryl, heteroaryl and heterocyclyl is optionally substituted with one or three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

68 . The method according to claim 67 , wherein the compound has Formula (VI):

69 . The method according to claim 56 , wherein the compound has Formula (VII):

wherein

R 140 is selected from the group consisting of H, —OH, halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 ;

xa and xb denote numbers that are each independently selected from 0, 1 and 2; and

R 150 and R 160 are independently selected from the group consisting of H, halo, —CN, —CF 3 , —OCF 3 , —C 1 -C 6 alkyl, —C 1 -C 6 alkoxyl, —O—C 2 -C 6 alkyl-O—R 53 , —OR 53 , —C 0 -C 6 alkyl-S(O) 0-2 —R 53 , —C 0 -C 6 alkyl-C(O)—R 53 , —C 0 -C 6 alkyl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)—R 53 , —C 0 -C 6 alkyl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 S(O) 2 —R 3 , —C 0 -C 6 alkyl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-NR 52 C(O)O—R 53 , —C 0 -C 6 alkyl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-C(O)O—R 53 , —C 0 -C 6 alkyl-OC(O)—R 3 , —C 0 -C 6 alkyl-aryl, —C 0 -C 6 alkyl-heteroaryl, —C 0 -C 6 alkyl-cycloalkyl, —C 0 -C 6 alkyl-heterocyclyl, —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 , —O—C 2 -C 6 alkyl-NR 50 R 51 , —NR 53 —C 2 -C 6 alkyl-NR 50 R 51 and —O-heterocyclyl-R 53 , wherein each alkyl and heteroalkyl is optionally substituted with one or three substituents independently selected from the group consisting of F, —OH and oxo, and wherein each aryl, heteroaryl, cycloalkyl and heterocyclyl is optionally substituted with one or two substituents independently selected from the group consisting of halo, —CN, —C 1 -C 4 alkyl, —C 1 -C 4 alkoxyl, —O—C 2 -C 4 alkyl-O—C 1 -C 4 alkyl, —CF 3 , —OCF 3 , —NO 2 , —C 1 -C 6 alkyl-S(O) 0-2 R 53 , —NH 2 , —NR 50 R 51 , —C 1 -C 6 alkyl-NR 50 R 51 and —N(C 1 -C 6 alkyl) 2 ;

R 50 and R 51 are independently selected from the group consisting of H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, wherein each alkyl and cycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

or

R 50 and R 51 , together with the N atom to which they are attached, optionally form a 3-10 membered heterocyclic ring, wherein the heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 52 is independently selected from the group consisting of —H, —C 1 -C 6 alkyl, —C 2 -C 6 alkyl-O—C 1 -C 6 alkyl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, wherein each alkyl and cycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl;

R 3 is independently selected from the group consisting of —C 1 -C 6 alkyl, —C 0 -C 4 alkyl-C 3 -C 7 cycloalkyl, —C 0 -C 4 alkyl-aryl, —C 0 -C 4 alkyl-heteroaryl and —C 0 -C 4 alkyl-heterocyclyl, wherein each alkyl, aryl, heteroaryl and heterocyclyl is optionally substituted with one or three substituents independently selected from the group consisting of halo, —OH, amino, —CN or —C 1 -C 4 alkyl; and

R 3 is independently selected from the group consisting of —H, alkyl, C 0 -C 3 alkyl-heterocyclyl, C 1 -C 3 alkyl-C 2 -C 6 alkenyl, C 1 -C 3 alkyl-C 2 -C 3 alkynyl, —C 2 -C 4 alkyl-OR 1 , —C 2 -C 4 alkyl-NR 3b R 3c , —C 2 -C 4 alkyl-NR 1 R 2 , heteroalkyl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C(O)—NR 3b R 3c , —C(O)—NR 1 R 2 , —C(O)—OR 1 , —S(O) 2 —NR 1 R 2 , —S(O) 2 —R 1 , —C(O)—R 1 , —C 3 -C 6 cycloalkyl, —C 0 -C 3 alkyl-C 3 -C 7 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, C 0 -C 3 alkyl-heteroaryl and heteroaryl, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted with from one to three independently selected substituents; wherein

R 1 and R 2 are independently selected from the group consisting of —H, C 1 -C 6 alkyl, aryl, heteroaryl, heterocyclyl, cycloalkyl and a protecting group; and

wherein R 3b and R 3c , together with the atom to which they are attached, optionally form a heterocyclic ring, wherein the heterocyclyl moiety is optionally substituted.

70 . The method according to claim 69 , wherein R 3 is R 180 , wherein R 180 is selected from the group consisting of H, —C 1 -C 6 alkyl, —C 1 -C 6 alkenyl, —C 1 -C 6 alkynyl, —C 2 -C 6 alkoxyl, —C 2 -C 6 alkyl-O—R 53 , —OR 53 , —C 2 -C 6 alkyl-S(O) 0-2 —R 53 , —C 2 -C 6 alkyl-C(O)—R 53 , —C 2 -C 6 alkyl-C(O)NR 50 R 51 , —C 2 -C 6 alkyl-NR 52 C(O)—R 53 , —C 2 -C 6 alkyl-S(O) 2 NR 50 R 51 , —C 2 -C 6 alkyl-NR 52 S(O) 2 —R 53 , —C 2 -C 6 alkyl-OC(O)NR 50 R 51 , —C 2 -C 6 alkyl-NR 52 C(O)O—R 53 , —C 2 -C 6 alkyl-NR 52 C(O)NR 50 R 51 , —C 2 -C 6 alkyl-C(O)O—R 53 , —C 2 -C 6 alkyl-OC(O)—R 53 , —C 0 -C 6 alkyl-heterocyclyl-R 53 , —C 0 -C 6 alkyl-heterocyclyl-O—R 53 , —C 0 -C 6 alkyl-heterocyclyl-S(O) 0-2 —R 53 , —C 0 -C 6 alkyl-heterocyclyl-C(O)—R 3 , —C 0 -C 6 alkyl-heterocyclyl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-heterocyclyl-NR 2 C(O)—R 3 , —C 0 -C 6 alkyl-heterocyclyl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-heterocyclyl-NR 2 S(O) 2 —R 53 , —C 0 -C 6 alkyl-heterocyclyl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-heterocyclyl-NR 2 C(O)O—R 3 , —C 0 -C 6 alkyl-heterocyclyl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-heterocyclyl-C(O)O—R 53 , —C 0 -C 6 alkyl-heterocyclyl-OC(O)—R 53 , —C 0 -C 6 alkyl-cycloalkyl-R 53 , —C 0 -C 6 alkyl-cycloalkyl-O—R 53 , —C 0 -C 6 alkyl-cycloalkyl-S(O) 0-2 —R 53 , —C 0 -C 6 alkyl-cycloalkyl-C(O)—R 3 , —C 0 -C 6 alkyl-cycloalkyl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-cycloalkyl-NR 52 C(O)—R 53 , —C 0 -C 6 alkyl-cycloalkyl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-cycloalkyl-NR 52 S(O) 2 —R 53 , —C 0 -C 6 alkyl-cycloalkyl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-cycloalkyl-NR 52 C(O)O—R 53 , —C 0 -C 6 alkyl-cycloalkyl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-cycloalkyl-C(O)O—R 53 , —C 0 -C 6 alkyl-cycloalkyl-OC(O)—R 53 , —C 0 -C 6 alkyl-heteroaryl-R 53 , —C 0 -C 6 alkyl-heteroaryl-O—R 53 , —C 0 -C 6 alkyl-heteroaryl-S(O) 0-2 —R 53 , —C 0 -C 6 alkyl-heteroaryl-C(O)—R 53 , —C 0 -C 6 alkyl-heteroaryl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-heteroaryl-NR 52 C(O)—R 53 , —C 0 -C 6 alkyl-heteroaryl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-heteroaryl-NR 52 S(O) 2 —R 3 , —C 0 -C 6 alkyl-heteroaryl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-heteroaryl-NR 2 C(O)O—R 53 , —C 0 -C 6 alkyl-heteroaryl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-heteroaryl-C(O)O—R 53 , —C 0 -C 6 alkyl-heteroaryl-OC(O)—R 53 , —C 0 -C 6 alkyl-aryl-R 53 , —C 0 -C 6 alkyl-aryl-O—R 53 , —C 0 -C 6 alkyl-aryl-S(O) 0-2 —R 53 , —C 0 -C 6 alkyl-aryl-C(O)—R 3 , —C 0 -C 6 alkyl-aryl-C(O)NR 50 R 51 , —C 0 -C 6 alkyl-aryl-NR 52 C(O)—R 53 , —C 0 -C 6 alkyl-aryl-S(O) 2 NR 50 R 51 , —C 0 -C 6 alkyl-aryl-NR 52 S(O) 2 —R 53 , —C 0 -C 6 alkyl-aryl-OC(O)NR 50 R 51 , —C 0 -C 6 alkyl-aryl-NR 52 C(O)O—R 3 , —C 0 -C 6 alkyl-aryl-NR 52 C(O)NR 50 R 51 , —C 0 -C 6 alkyl-aryl-C(O)O—R 3 , —C 0 -C 6 alkyl-aryl-OC(O)—R 3 , —C 0 -C 6 alkyl-aryl, —C 0 -C 6 alkyl-heteroaryl, —C 0 -C 6 alkyl-cycloalkyl, —C 0 -C 6 alkyl-heterocyclyl and —C 2 -C 6 alkyl-NR 50 R 51 , wherein each alkyl and heteroalkyl is optionally substituted with one to three substituents independently selected from the group consisting of F, —OH and oxo, wherein each aryl, heteroaryl, cycloalkyl and heterocyclyl is optionally substituted with one or two substituents.

70 . A method for treating a cognitive disorder or deficit comprising administering a compound selected from the group consisting of:

(Z)-4-(dibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)-4-(dibenzo[b,f][1,4]thiazepin-11-yl)-N-hydroxybenzamide,

4-(10,11-dihydrodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

N-hydroxy-4-(10-methyl-10,11-dihydrodibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(8-chloro-5H-dibenzo[b,e][1,4]diazepin-11-yl)-N-hydroxybenzamide,

(Z)-4-(benzo[b]pyrido[3,2-f][1,4]oxazepin-5-yl)-N-hydroxybenzamide,

(Z)-4-(2-fluorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(2-methoxydibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(benzo[b]pyrido[4,3-f][1,4]oxazepin-5-yl)-N-hydroxybenzamide,

(Z)-4-(2-(2-(dimethylamino)ethoxy)dibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(8-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(dibenzo[b,f][1,4]oxazepin-11-yl)-2-fluoro-N-hydroxybenzamide,

(Z)-5-(4-(hydroxycarbamoyl)phenyl)benzo[b]pyrido[4,3-f][1,4]oxazepine 2-oxide,

(Z)—N-hydroxy-4-(3-methoxydibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-3-(dibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(8-methyldibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(4-methoxydibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(9-fluorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(7-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(7-chlorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)-4-(2-chlorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)-4-(8-cyanodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(4-methyldibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(3-methyldibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(benzo[b]thieno[2,3-f][1,4]oxazepin-1-yl)-N-hydroxybenzamide,

(Z)-4-(3-fluorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)-4-(8-chlorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(3-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(6-fluorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)-4-(7-cyanodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(4-hydroxydibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(1-methoxydibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(4-(2-methoxyethoxy)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(1-fluorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(2-(trifluoromethyl)benzo[f]pyrido[2,3-b][1,4]oxazepin-6-yl)benzamide,

(Z)-4-(11-cyclopropyl-11H-benzo[b]pyrido[2,3-e][1,4]diazepin-5-yl)-N-hydroxybenzamide,

(Z)-4-(5-cyclopropyl-5H-dibenzo[b,e][1,4]diazepin-11-yl)-N-hydroxybenzamide,

(Z)-4-(5H-dibenzo[b,e][1,4]diazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(4-(2-morpholinoethoxy)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(benzo[f]pyrido[2,3-b][1,4]oxazepin-6-yl)-N-hydroxybenzamide,

(Z)-4-(2-fluoro-4-methoxydibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(4-(methylthio)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(4-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(4-(methylsulfinyl)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)-4-(5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(4-(methyl sulfonyl)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(E)-4-((dibenzo[b,f][1,4]oxazepin-11-ylamino)methyl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(4-methoxy-8-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(3-morpholinodibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(4-propyldibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(4-(trifluoromethoxy)dibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(Z)—N-hydroxy-4-(6-methyldibenzo[b,f][1,4]oxazepin-11-yl)benzamide,

(E)-4-(dibenzo[b,f][1,4]oxazepin-11-yl)-3-fluoro-N-hydroxybenzamide,

(E)-6-(dibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxynicotinamide,

(E)-5-(dibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxyfuran-2-carboxamide,

(E)-5-(dibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxythiophene-2-carboxamide,

(Z)-4-(5-ethyl-5H-dibenzo[b,e][1,4]diazepin-11-yl)-N-hydroxybenzamide,

(Z)-4-(5-cyclopropyl-5H-dibenzo[b,e][1,4]diazepin-11-yl)-N-hydroxy-N-methylbenzamide,

(Z)—N-hydroxy-4-(5-isopropyl-5H-dibenzo[b,e][1,4]diazepin-11-yl)benzamide,

(E)-4-((5-cyclopropyl-5H-dibenzo[b,e][1,4]diazepin-11-ylamino)methyl)-N-hydroxybenzamide,

(Z)-4-(4-fluorodibenzo[b,f][1,4]oxazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(5-(2-methoxyethyl)-5H-dibenzo[b,e][1,4]diazepin-11-yl)benzamide,

(E)-4-(2-(dibenzo[b,f][1,4]oxazepin-11-ylamino)ethyl)-N-hydroxybenzamide,

(Z)-4-(11-ethyl-11H-benzo[b]pyrido[2,3-e][1,4]diazepin-5-yl)-N-hydroxybenzamide,

(Z)-4-(5-cyclopropyl-2-fluoro-5H-dibenzo[b,e][1,4]diazepin-11-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(11-isopropyl-11H-benzo[b]pyrido[2,3-e][1,4]diazepin-5-yl)benzamide,

(Z)-4-(benzo[f]thieno[2,3-b][1,4]oxazepin-5-yl)-N-hydroxybenzamide,

(Z)-6-(4-(dibenzo[b,f][1,4]oxazepin-11-yl)benzamidooxy)-3,4, 5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid,

(Z)—N-hydroxy-4-(11-(3-morpholinopropyl)-11H-benzo[b]pyrido[2,3-e][1,4]diazepin-5-yl)benzamide,

(Z)—N-hydroxy-4-(11-(2-morpholinoethyl)-11H-benzo[b]pyrido[2,3-e][1,4]diazepin-5-yl)benzamide,

(Z)-4-(11-(cyclopropylmethyl)-11H-benzo[b]pyrido[2,3-e][1,4]diazepin-5-yl)-N-hydroxybenzamide,

(Z)—N-hydroxy-4-(5-(2-morpholinoethyl)-5H-dibenzo[b,e][1,4]diazepin-11-yl)benzamide,

or a pharmaceutically acceptable salt thereof.

72 . A method for treating a cognitive disorder or deficit comprising administering an effective amount of the compound of Formula VIII:

or a pharmaceutically acceptable salt thereof, wherein

R 4 is independently selected from the group consisting of —H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl-R 3 , —C 0 -C 6 alkyl-OR 3 , —C 0 -C 6 alkyl-OR 1 , —C 0 -C 6 alkyl-C(O)—OR 3 , —C 0 -C 6 alkyl-C(O)NR 3 R 3a , —CH═CH—C(O)—OR 3 , —CH═CH—C(O)—N(R 3 )(R 3a ), —N(R 3 )—C(O)—CF 3 , —N(R 3 )—C 2 -C 6 alkyl-N(R 3 )(R 3a ), —C 0 -C 6 alkyl-N(R 3 )(R 3a ), —N(R 3 )—C(O)—C 1 -C 6 alkyl-R 3 , —N(R 3 )—S(O) 2 —C 1 -C 6 alkyl-R 3 , —S(O) 2 —N(R 3 )R 3a , —O—C 2 -C 6 alkyl-N(R 3 )(R 3a ), —O—C 2 -C 6 alkyl-OR 1 , —S—R 3 , —S(O)—C 1 -C 6 alkyl-R 3 , —S(O) 2 —C 1 -C 6 alkyl-R 3 , C 3 -C 6 cycloalkyl, heterocyclyl, C 4 -C 7 heterocyclyl-R 3 , —O—C 2 -C 4 alkyl-heterocyclyl, —O-heterocyclyl-C(O)—OR 3 , —O—C 0 -C 4 alkyl-aryl, —O—C 0 -C 4 alkyl-heteroaryl, —O—C(O)—NR 3 -C 0 -C 4 alkyl-aryl, —O—C(O)—NR 3 -C 0 -C 4 alkyl-heteroaryl, —O—C 0 -C 4 alkyl-heterocyclylaryl, —O—C 0 -C 4 alkyl-heterocyclyl-heteroaryl, —N(R 3 )—C 2 -C 4 alkyl-heterocyclyl, —N(R 3 )C(O)N(R 3 )—C 0 -C 4 alkyl-heterocyclyl-R 3 , —C 0 -C 4 alkyl-OC(O)—R 3 , —C 0 -C 4 alkyl-N(R 3 )C(O)—O—R 3 , —C 0 -C 4 alkyl-heterocyclyl-C(O)—O—R 3 , —N(R 3 )—C 2 -C 4 alkyl-heterocyclyl, F, Cl, Br, I, NO 2 , —CF 3 , —OCF 3 , —OCHF 2 , —SCF 3 , —SF 5 , —SO 3 H, —CN, —C 1 -C 6 alkylaryl, aryl, heteroaryl, cycloalkyl, —C 1 -C 6 alkylheteroaryl, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moeity of the aformentioned R 4 is optionally substituted;

each A is independently selected from the group consisting of N, —N-oxide, —CH═ and —C(R 4 )═, wherein no more than two A per 5 or 6 membered ring are N, and wherein no more than one A is —N-oxide;

Z is —N(R′)OR 2 or H;

L is a covalent bond or —C 0 -C 3 alkyl-N(OR 2 )—;

wherein, when L is C 0 -C 3 alkyl-N(OR 2 )—, then Z is H; and

wherein, when Z is H, then L is —C 0 -C 3 alkyl-N(OR 2 )—;

G 2 is carbon or N;

U 2 is selected from the group consisting of a covalent bond, —C 1 -C 8 alkyl-, —C(R 300 )(R 400 )—, —C(O)—C(R 301 )(R 401 )—, —C 0 -C 2 alkyl-C(O)—O—C 0 -C 4 alkyl-, —C 0 -C 2 alkyl-C(O)—C 0 -C 4 alkyl-, —C 0 -C 2 alkyl-C(O)—NR 3 -C 0 -C 4 alkyl-, —C(O)—O—C(R 301 )(R 401 )—, —C(O)—C(R 301 )(R 401 )— and —C(O)—NR 3 -C(R 300 )(R 400 )—,

each R 3 is independently selected from the group consisting of —H, alkyl, C 0 -C 3 alkyl-heterocyclyl, C 1 -C 3 alkyl-C 2 -C 6 alkenyl, C 1 -C 3 alkyl-C 2 -C 3 alkynyl, —C 2 -C 4 alkyl-OR 1 , —C 2 -C 4 alkyl-NR 3b R 3c , —C 2 -C 4 alkyl-NR 1 R 2 , heteroalkyl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C(O)—NR 3b R 3c , —C(O)—NR 1 R 2 , —C(O)—OR 1 , —S(O) 2 —NR 1 R 2 , —S(O) 2 —R, —C(O)—R 1 , —C 3 -C 6 cycloalkyl, —C 0 -C 3 alkyl-C 3 -C 7 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, C 0 -C 3 alkyl-heteroaryl and heteroaryl, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted with from one to three independently selected substituents,

each R 3a is independently selected from the group consisting of —H, alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl, covalent bond, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted;

wherein R 3 and R 3a , together with the atom to which they are attached, optionally form a heterocyclic ring, wherein the heterocyclyl moiety is optionally substituted;

R 300 and R 400 are independently selected from the group consisting of —H, —F, —C 1 -C 6 alkyl, aryl, heteroaryl, heterocyclyl and cycloalkyl;

R 301 and R 401 are independently selected from the group consisting of —H, F, OR 1 , —NR 3 R 3a , —C 1 -C 6 alkyl, aryl, heteroaryl, heterocyclyl and cycloalkyl;

R 200 , R 201 , R 202 and R 203 are independently selected from the group consisting of —H, —C 1 -C 6 alkyl, aryl, heteroaryl, heterocyclyl and cycloalkyl; and

is selected from the group consisting of hydrogen, aryl, heteroaryl, alkyl, heterocyclyl, cycloalkyl, wherein each aryl, heteroaryl, cycloalkyl and heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —CF 3 , —OCF 3 , —SCF 3 , —SF 5 , —NO 2 , —CN, —C 1 -C 6 alkyl, —C 1 -C 6 alkoxyl, —O—C 2 -C 6 alkyl-O—R 1 , —O—R 1 , —OCF 2 H, —C 0 -C 6 alkyl-S(O) 0-2 —R 1 , —C 0 -C 6 alkyl-C(O)—R 1 , —C 0 -C 6 alkyl-C(O)NR 3 R 3a , —C 0 -C 6 alkyl-NR 3 C(O)—R 2 , —C 0 -C 6 alkyl-S(O) 2 NR 3 R 3a , —C 0 -C 6 alkyl-NR 3 S(O) 2 —R 2 , —C 0 -C 6 alkyl-OC(O)NR 3 R 3a , —C 0 -C 6 alkyl-NR 3 C(O)O—R 1 , —C 0 -C 6 alkyl-NR 1 C(O)NR 3 R 3a , —C 0 -C 6 alkyl-C(O)O—R 1 , —C 0 -C 6 alkyl-OC(O)—R 1 , —C 0 -C 6 alkyl-aryl, —C 0 -C 6 alkyl-heteroaryl, —C 0 -C 6 alkyl-C 3 -C 6 cycloalkyl, —C 0 -C 6 alkyl-heterocyclyl, —C 0 -C 6 alkyl-NR 3 R 3a and —O—C 2 -C 6 alkyl-NR 3 R 3a ; and

R 1 and R 2 are independently selected from the group consisting of —H, C 1 -C 6 alkyl, aryl, heteroaryl, heterocyclyl, cycloalkyl and a protecting group.

73 . The method according to claim 72 , wherein the moiety

74 . The method according to claim 72 , wherein the moiety

75 . The method according to any of claims 72 to 74 , wherein the moiety

is a radical selected from the group consisting of

76 . The method according to any of claims 72 to 75 , wherein the moiety

is a radical selected from the group consisting of

or an enantiomer thereof, a scalemic thereof, or a mixture of enantiomers thereof.

77 . The method according to any of claims 72 to 76 , wherein U 2 is a covalent bond.

78 . The method according to any of claims 72 to 76 , wherein U 2 is selected from the group consisting of a —C 1 -C 4 alkyl, —CH(aryl)-, —CH(heteroaryl)-, —C(O)—, —C(O)—CH(aryl)-, —C(O)—CH(heteroaryl)-, —C(O)O— C 1 -C 2 alkyl-, —C(O)O— and —C(O)NH—.

79 . The method according to any of claims 72 to 78 , wherein the moiety

is a radical selected from the group consisting of H, alkyl, aryl, heteroaryl, cycloalkyl and heterocyclyl, wherein each aryl, heteroaryl, cycloalkyl and heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of halo, —CF 3 , —OCF 3 , —SCF 3 , —SF 5 , —CN, —C 1 -C 6 alkyl, —O—C 2 -C 6 alkyl-O—R 1 , —O—R 1 , —OCF 2 H, —C 0 -C 6 alkyl-S(O) 0-2 —R 1 , —C 0 -C 6 alkyl-C(O)NR 3 R 3a , —C 0 -C 6 alkyl-NR 3 C(O)—R 2 , —C 0 -C 6 alkyl-S(O) 2 NR 3 R 3a , —C 0 -C 6 alkyl-NR 3 S(O) 2 —R 2 , —C 0 -C 6 alkyl-OC(O)NR 3 R 3a , —C 0 -C 6 alkyl-NR 3 C(O)O—R 1 , —C 0 -C 6 alkyl-NR 1 C(O)NR 3 R 3a , —C 0 -C 6 alkyl-C(O)O—R 1 , —C 0 -C 6 alkyl-OC(O)—R 1 , —C 0 -C 6 alkyl-aryl, —C 0 -C 6 alkyl-heteroaryl, —C 0 -C 6 alkyl-C 3 -C 7 cycloalkyl, —C 0 -C 6 alkyl-heterocyclyl, —C 0 -C 6 alkyl-NR 3 R 3a and —O—C 2 -C 6 alkyl-NR 3 R 3a .

80 . The method according to any of claims 72 to 78 , wherein the moiety

is a radical selected from the group consisting of

81 . The method according to claim 72 , wherein the compound has Formula (IX):

or where possible, a (R,R) or (S,S) enantiomer, scalemic or a mixture of enantiomers thereof.

82 . The method according to claim 72 , represented by the Formula (X):

or where possible, a (R,R) or (S,S) enantiomer, scalemic or a mixture of enantiomers thereof.

83 . The method according to claim 72 , wherein the moiety

is a radical selected from the group consisting of

84 . A method for treating a cognitive disorder or deficit comprising administering a compound selected from the group consisting of:

2-((1S,4S)-5-benzyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-p-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

2-((1S,4S)-5-benzhydryl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-5-(4-chlorophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

(1S,4S)-tert-butyl 5-(5-(hydroxycarbamoyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate,

2-((1S,4S)-5-(3-fluorophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-5-(4-fluorophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-o-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-phenyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

2-((1S,4S)-5-benzoyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(3-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

2-((1S,4S)-5-(2-fluoro-4-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(2-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(4-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

2-((1S,4S)-5-(benzo[c][1,2,5]oxadiazol-5-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-5-(benzo[c][1,2,5]thiadiazol-5-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(3-(trifluoromethyl)benzoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

2-((1S,4S)-5-(benzo[d][1,3]dioxol-5-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-5-(cyclohexanecarbonyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-5-(2,2-diphenylacetyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-4-((1S,4S)-5-p-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

(1S,4S)-benzyl 5-(5-(hydroxycarbamoyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate,

(1S,4S)-isobutyl 5-(5-(hydroxycarbamoyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate,

N-hydroxy-2-((1S,4S)-5-(3-(trifluoromethoxy)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

2-((1S,4S)-5-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(3-(trifluoromethylthio)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(4-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(2-(trifluoromethyl)quinolin-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

2-((1S,4S)-5-(3-(difluoromethoxy)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(6-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

(1S,4S)-cyclopentyl 5-(5-(hydroxycarbamoyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate,

2-((1S,4S)-5-(benzo[c][1,2,5]oxadiazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(5-(trifluoromethyl)pyridin-3-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-2-((1R,4R)-5-p-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

(1S,4S)-isopropyl 5-(5-(hydroxycarbamoyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate,

(1S,4S)-pyridin-3-ylmethyl 5-(5-(hydroxycarbamoyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate,

(1S,4S)-cyclopropylmethyl 5-(5-(hydroxycarbamoyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate,

(1S,4S)-tetrahydro-2H-pyran-4-yl 5-(5-(hydroxycarbamoyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate,

2-((1S,4S)-5-(3,5-bis(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-5-(benzo[d]isoxazol-3-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-5-(3-(dimethylcarbamoyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

2-((1S,4S)-5-(3-((dimethylamino)methyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(3-methoxyphenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-m-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-6-(5-p-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)nicotinamide,

N-hydroxy-5-((1S,4S)-5-(3-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrazine-2-carboxamide,

2-fluoro-N-hydroxy-4-((1S,4S)-5-(3-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

N-hydroxy-2-((1S,4S)-5-(pyrrolidine-1-carbonyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-2-((1S,4S)-5-(4-(trifluoromethyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-6-((1S,4S)-5-(3-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyridazine-3-carboxamide,

N-hydroxy-2-((1R,4R)-5-(4-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

N-hydroxy-2-((1R,4R)-5-m-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)pyrimidine-5-carboxamide,

2-(5-(3-cyanophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxypyrimidine-5-carboxamide,

N-hydroxy-4-(5-(3-methoxyphenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

N-hydroxy-4-(5-m-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

N-hydroxy-4-((1S,4S)-5-(3-(trifluoromethyl)phenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

N-hydroxy-4-((1S,4S)-5-(4-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

4-((1S,4S)-5-(3-cyanophenyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-hydroxybenzamide,

N-hydroxy-4-((1R,4R)-5-m-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

N-hydroxy-4-((1R,4R)-5-(4-(trifluoromethyl)pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

N-hydroxy-4-((1S,4S)-5-(4-(trifluoromethyl)pyrimidin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide,

N-hydroxy-N-methyl-4-((1S,4S)-5-p-tolyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzamide and

85 . The method according to claim 1 , wherein the compound has Formula (XI):

and pharmaceutically acceptable salts thereof,

wherein

is

and

Q is selected from the group consisting of —C 1 -C 6 alkyl, covalent bond, —C 0 -C 6 alkyl-O—C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-NR 3 —C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-S(O) 0-2 -C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-NR 3 C(O)—C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-C(O)NR 3 —C 0 -C 6 alkyl- and —C 0 -C 6 alkyl-OC(O)NR 3 —C 0 -C 6 alkyl-.

86 . The method according to claim 85 , wherein the moiety

is selected from a radical consisting of

87 . The method according to claim 1 , wherein the compound has Formula (XII):

and pharmaceutically acceptable salts thereof,

wherein

is

and

Q 2 is selected from the group consisting of —C 1 -C 6 alkyl, covalent bond, —C 0 -C 6 alkyl-O—C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-NR 3 —C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-S(O) 0-2 -C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-NR 3 C(O)—C 0 -C 6 alkyl-, —C 0 -C 6 alkyl-C(O)NR 3 —C 0 -C 6 alkyl- and —C 0 -C 6 alkyl-OC(O)NR 3 —C 0 -C 6 alkyl-.

88 . The method according to claim 87 , wherein the moiety

is selected from a radical consisting of

89 . The method according to claim 1 , wherein the compound has Formula (XIII):

and pharmaceutically acceptable salts thereof,

wherein

is a radical selected from the group consisting of

90 . The method according to claim 1 , wherein the compound has Formula (XIV):

and pharmaceutically acceptable salts thereof,

wherein

is a radical selected from the group consisting of aryl, heteroaryl, heterocyclyl, cycloalkyl,

wherein each aryl, heteroaryl, cycloalkyl and heterocyclyl is optionally substituted.

91 . The method according to claim 52 , wherein

and are independently selected from the group consisting of phenyl, heteroaryl and heterocyclyl, wherein each phenyl, heteroaryl and heterocyclyl is optionally substituted with one to three substituents independently selected from the group consisting of R 4 , wherein

R 4 is independently selected from the group consisting of —H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl-R 3 , —C 0 -C 6 alkyl-OR 3 , —C 0 -C 6 alkyl-OR 1 , —C 0 -C 6 alkyl-C(O)—OR 3 , —C 0 -C 6 alkyl-C(O)NR 3 R 3a , —CH═CH—C(O)—OR 3 , —CH═CH—C(O)—N(R 3 )(R 3a ), —N(R 3 )—C(O)—CF 3 , —N(R 3 )—C 2 -C 6 alkyl-N(R 3 )(R 3a ), —C 0 -C 6 alkyl-N(R 3 )(R 3a ), —N(R 3 )—C(O)—C 1 -C 6 alkyl-R 3 , —N(R 3 )—S(O) 2 —C 1 -C 6 alkyl-R 3 , —S(O) 2 —N(R 3 )R 3a , —O—C 2 -C 6 alkyl-N(R 3 )(R 3a ), —O—C 2 -C 6 alkyl-OR 1 , —S—R 3 , —S(O)—C 1 -C 6 alkyl-R 3 , —S(O) 2 —C 1 -C 6 alkyl-R 3 , C 3 -C 6 cycloalkyl, heterocyclyl, C 4 -C 7 heterocyclyl-R 3 , —O—C 2 -C 4 alkyl-heterocyclyl, —O-heterocyclyl-C(O)—OR 3 , —O—C 0 -C 4 alkyl-aryl, —O—C 0 -C 4 alkyl-heteroaryl, —O—C(O)—NR 3 -C 0 -C 4 alkyl-aryl, —O—C(O)—NR 3 -C 0 -C 4 alkyl-heteroaryl, —O—C 0 -C 4 alkyl-heterocyclylaryl, —O—C 0 -C 4 alkyl-heterocyclyl-heteroaryl, —N(R 3 )—C 2 -C 4 alkyl-heterocyclyl, —N(R 3 )C(O)N(R 3 )—C 0 -C 4 alkyl-heterocyclyl-R 3 , —C 0 -C 4 alkyl-OC(O)—R 3 , —C 0 -C 4 alkyl-N(R 3 )C(O)—O—R 3 , —C 0 -C 4 alkyl-heterocyclyl-C(O)—O—R 3 , —N(R 3 )—C 2 -C 4 alkyl-heterocyclyl, F, Cl, Br, I, NO 2 , —CF 3 , —OCF 3 , —OCHF 2 , —SCF 3 , —SF 5 , —SO 3 H, —CN, —C 1 -C 6 alkylaryl, aryl, heteroaryl, cycloalkyl, —C 1 -C 6 alkylheteroaryl, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moeity of the aformentioned R 4 is optionally substituted; wherein

each R 3 is independently selected from the group consisting of —H, alkyl, C 0 -C 3 alkyl-heterocyclyl, C 1 -C 3 alkyl-C 2 -C 6 alkenyl, C 1 -C 3 alkyl-C 2 -C 3 alkynyl, —C 2 -C 4 alkyl-OR 1 , —C 2 -C 4 alkyl-NR 3b R 3c , —C 2 -C 4 alkyl-NR 1 R 2 , heteroalkyl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C(O)—NR 3b R 3c , —C(O)—NR 1 R 2 , —C(O)—OR 1 , —S(O) 2 —NR 1 R 2 , —S(O) 2 —R, —C(O)—R 1 , —C 3 -C 6 cycloalkyl, —C 0 -C 3 alkyl-C 3 -C 7 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, C 0 -C 3 alkyl-heteroaryl and heteroaryl, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted with from one to three independently selected substituents,

each R 3a is independently selected from the group consisting of —H, alkyl, heterocyclyl, C 2 -C 6 alkenyl, C 2 -C 3 alkynyl, C 2 -C 4 alkyl-OR 1 , heteroalkyl, heteroaryl, C 0 -C 6 alkylheteroaryl, C(O)CF 3 , —C(O)—NH 2 , —C 3 -C 6 cycloalkyl, -alkyl-C 3 -C 6 cycloalkyl, —C 1 -C 6 alkylaryl, aryl, alkylheteroaryl and heteroaryl, covalent bond, wherein each alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl and heteroaryl moiety is optionally substituted;

wherein R 3 and R 3a , together with the atom to which they are attached, optionally form a heterocyclic ring, wherein the heterocyclyl moiety is optionally substituted;

wherein R 3b and R 3c , together with the atom to which they are attached, optionally form a heterocyclic ring, wherein the heterocyclyl moiety is optionally substituted; and

R 1 and R 2 are independently selected from the group consisting of —H, C 1 -C 6 alkyl, aryl, heteroaryl, heterocyclyl, cycloalkyl and a protecting group.

92 . The method of claims 1 - 91 wherein the causation of the cognitive disorder is a neurodegenerative disease

93 . The method of claims 1 - 91 wherein the causation of the cognitive disorder is a polyglutamine disease.

94 . The method of claims 1 - 91 wherein the causation of the cognitive disorder is a Tauopathy.

95 . The method of claim 92 wherein the causation the cognitive disorder is caused by Alzheimer's Disease

96 . The method of claim 93 wherein causation the cognitive disorder is caused by Huntington's Disease